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Abstract
Introduction: Late diagnosis and presentation to HIV/AIDS care lessens the benefits
of antiretroviral therapy and increase risk of HIV/AIDS transmission. A large number
of people present late for HIV care despite free accessible HIV care services. The
factors hindering patients’ early presentation to HIV care when HIV/AIDS care
services are accessible in lower health facilities is not known in Ethiopia.
Objectives: This study was conducted to identify determinants of late presentation to
HIV/AIDS care among HIV positives enrolled in HIV chronic care in Health institutions
in southern zone of Tigray, Northern Ethiopia.
Methods: An Institution based un-matched case-control study, supported with
phenomenology was conducted, among HIV positives enrolled in 6 HIV chronic care
clinics in Southern Tigray from March to April, 2014.Cases were late presenters_CD4
count <350 cells/μl or WHO stages 3 or 4 and Controls were with CD4 ≥ 350 cells/μl
and WHO stages 1 or 2 at first visit. Using 1:2, case: control ratio, 147 cases and 295
controls were included and selected systematically. Multiple logistic regression
models were used to identify determinants of late presentation.Qualitative data was
analyzed using thematic analysis complementing quantitative findings.
Result: A total of 147 cases and 266 controls participated in the study. In the
multiple logistic regression participants aged 25-29 (AOR = 3, CI: 1.2-8.1) and 35-
39(AOR = 4.1, CI: 1.4-12.5), having two (AOR = 6,CI: 1.3-28) and more( AOR =
5.2,CI: 1.1-24.8) lifetime sexual partners, with poor social support (AOR = 2.3,CI:
1.26-4.30), in the second  wealth quintile(AOR = 3.3,CI:1.3-8.5), who perceived
stigma (AOR = 4.4,CI: 2.2-8.3) and losing income(AOR= 6.8 CI: 1.8-24.5) as barrier,
reported severe illness(AOR = 4.3,CI: 2.26-8) as reason for care seeking presented
late, while  those who reported protecting family as reason for care(AOR = .19(.09 -
.37), presented in recent years and who disclosed HIV status to partner  (AOR =
0.5,CI : 0.24 - 0.95) presented early  compared to their counter parts . Use of non-
medical care and male sex also deter timely care in the FGD.
Conclusion: In this study, HIV positives of older ages, low socio-economic status
and poor social support, denying disclosure and having perception of barriers in
recieving HIV care presented late.Efforts towards promoting early care seeking
should target these factors in the area and similar settings.
Key words: Late presentation, Determinants, Health center, Case-control, Ethiopia
11. Introduction
1.1. Statement of the problem
More than 35.3 million people are living with HIV globally of which Sub- Saharan
Africa accounts for 69% of the global HIV burden[1]. In Ethiopia ,the total number of
HIV-positive people was estimated to be over 1.2 million [2].
Due to the availability of Antiretroviral Therapy (ART), contracting HIV is no longer an
automatic death sentence. However, late presentation to HIV/AIDS care minimizes
the benefit of ART and is deriving the HIV/AIDS epidemic due to uncontrolled viremia
and unknown serostatus [3-5]. According to European Late Presenter Consensus
Working group (ELPCWG), late presentation is defined as any patient who presents
with a CD4 cell count of < 350 cells/mm3 at first visit to HIV care and presentation
with advanced HIV disease is defined as persons presenting for care with a CD4
count below 200 cells/ μl or AIDS-defining event, regardless of the CD4 cell count [6].
Including the developed countries, a substantial numbers of patients continue to
present for care only when they have reached an advanced stage of disease [4, 5, 7-
12]. Roughly 15–43 % HIV-infected individuals in the developed world, present at
clinics for care with advanced HIV disease [3, 13] and 40-60 % of PLHA present with
CD4 count of < 350 cells/mm3 [4, 11]. In resource-limited settings, patients present
far later for care [4, 5, 12, 14]. In Sub-Saharan Africa 35 – 65 % present on average
with a CD4 cell count of < 200 cells/mm3 or with an AIDS-defining event [9, 13, 15,
16] ; 20_40% start ART with a CD4 of < 100 cells/mm3. Such late presentation is
associated with lower survival, early mortality particularly associated with
tuberculosis, and invasive bacterial and fungal infections [4]. Although findings on
late presentation are limited, the problem of late ART initiation and its poor outcomes
was reported by some researches in Ethiopia [7, 17, 18].One study in Arbaminch,
Ethiopia indicated that 65 % of patients presented late to HIV care(WHO stage III and
IV)[15].
2Late presentation has consequences both for the individual in terms of poor out
comes and for the society in terms of increased transmission. Late presentation and
subsequent late ART initiation is major reason for the high mortality rates observed
during the first months of ART[5, 8, 10, 19, 20] and the decreasing retention rates in
the course of ART[3, 5, 10, 13, 21]. In addition, late presentation poses a higher
cumulative risk of HIV transmission to others [11, 13, 22] and an economic burden to
individuals , with higher resource use, particularly in the first few months following
presentation [11]. Furthermore, late presentation means that opportunities to reduce
onward transmission, either by reducing high-risk behaviors or by reducing an
individual’s infectivity, are missed.
The determinants of late presentation in the developed world include older age, male
sex, risky behaviors (including injection drug, heterosexuality, transgender sex, and
alcohol use), lower income, as well as low degree of education [5, 11, 13].As
reported from previous studies[3, 5, 13],the reasons for late presentation to HIV care
in low income countries, particularly those in sub-Saharan Africa are diverse and
include, contextual/structural, clinical and individual level factors. Decentralizing and
improving access to HIV/AIDS care has been an onward strategy to promote early
presentation to care and timely care initiation in Sub Saharan Africa, including
Ethiopia[5, 23].
In Ethiopia, two hospital based studies, reported (demographic, geo-graphic,
psychosocial) factors for late presentation [24, 25].However, the determinants of late
presentation in such Higher, centralized hospitals may not represent the
characteristics of HIV positives who present in the local health center setting.
Thus, determinants of late presentation to HIV/AIDS care when HIV cares services
are accessible to lower health service units is not known in Ethiopia at large and
specifically in the study area. Apart from this, the effect of social support, use of non -
medical care and the individuals’ perceived need and perceived barriers to HIV care,
were not addressed adequately in previous studies.
31.2. Literature review
1.2.1. Magnitude of late presentation to HIV /AIDS care
Late presentation to HIV / AIDS had been reported from studies globaly[3, 11, 26, 27]
and in Sub- Saharan Africa countries[3, 16, 28, 29] although with varying definitions
such as CD4 counts (< 100 cells/mm3, < 250 cells/mm3, < 200 cells/mm3 and < 350
cells/mm3) or only using WHO stages[3, 16, 24, 25].Delayed access to HIV care after
HIV diagnosis is common even in the developed world. In New York City; the
epicenter for HIV in the U.S., HIV treatment has been widely available for more than
15 years. Yet, approximately 26% of people diagnosed with HIV have concomitant
diagnosis of AIDS at the time of HIV diagnosis [3]. Studies from Europe report that
around 50% of patients present late for care with CD4 count of < 350  cells/mm3 [4]
and 31.3 % present with CD4 count <200/mm3[26]. A Meta-analysis of data from 44
studies conducted in high-income countries reported that a mean annual CD4
increase of only1.5 cells/mm3 was achieved at treatment presentation between 1992
and 2011[4]. Thus, in sub-Saharan Africa, a major concern is that the problem of late
presentation and late ART initiation will reach a sub-optimal steady state similar to
the United States, where, despite substantial investment and near universal
availability of HIV-related services, an unprecedented number of people living with
HIV (including undiagnosed HIV) and several important service and programmatic
gaps continue to drive HIV incidence, and HIV-related morbidity and mortality at the
population-level[3].
Studies in sub-Saharan Africa indicate that huge number people delay to HIV care.
The low CD4 count at ART initiation, as observed in several studies in sub-Saharan
Africa [3, 7, 8, 13, 21], is attributed to the high frequency of late-stage presentation
among new HIV-positive patients[3, 5, 13, 16, 19-21, 28, 29].In a study evaluating the
role of home based testing for early uptake in Kenya, only 42 % of HIV positives
receiving home visits reported HIV care attendance[30].A cross-sectional analysis of
initial visits to the Immune Suppression Syndrome Clinic in Uganda, over one-third
(40%) were categorized as late presenters, that is WHO disease stage 3 or 4[13].A
study in South Africa indicated  that, 33.6%  of newly-diagnosed with HIV presented
with late-stage HIV disease(CD4 count < 100 cells/mm3)[16].
41.2.2. Determinants of late Presentation to HIV/AIDS care
Literatures emerge with new factors for late presentation to HIV care at different
study settings and contexts [13, 16, 24, 25, 30, 31]. In the developed world
determinants of late presentation include older age, male sex, risk behaviors
(including injection drug ,homosexuality, and alcohol use),lower income, as well as
limited knowledge about accessing testing or treatment on testing positive and
patients perspective about the impact of a positive result, fears around discrimination,
confidentiality, criminalization of risk behaviors[11, 13, 26, 32].
In sub-Saharan Africa determinant factors are diverse and include beyond the
individual level determinates measured at the contextual (nationwide or sub-national)
and clinic levels [3, 5, 7]. Studies in sub Saharan Africa on the patient level
determinants reported various aspects of it and this can be broadly categorized as
demographic, socioeconomic, behavioral, psychosocial and social environment
determinants[13, 16] and qualitative studies also reported perceived barriers and
benefits [23, 31, 33] at patient level. A systematic review from studies in sub Saharan
Africa on Risk factors, barriers and facilitators for linkage to antiretroviral therapy care
identified key areas of  individual level determinants  modifiable by interventions as
economic, psychosocial, medical and demographic factors [34].
1. Socio-demographic determinants
Various socio-demographic factors found to determine late presentation to HIV care
including sex, age, etc. Studies in South Africa [16],Nigeria[35]and India [36]
reported an increased likelihood of  late presentation  with male sex. Lahuerta et al.
on Factors Associated with Late Antiretroviral Therapy Initiation among Adults in
Mozambique using same definition ( stage IV) at ART initiation, reported  association
of female sex, with  less likelihood of late ART initiation[8]. Age was found to
determine late presentation to HIV care with some controversies at different settings.
A study in Belgium and France found that rates of late testing increase with age,
although it reported varying trend for the delayed presentation to care. Patients aged
30-49 years were at increased risk of delayed presentation to care and presentation
to care with advanced HIV disease compared to patients aged <30 years, but
5patients aged >50 years were not[26]. Older ages were associated with increased
odds of late presentation in other studies too;Nigeria[35] Uganda[13]and
Germany[37].In contrast, a study in India found an association of younger age with
delayed entry in men, but not in women[36]. Younger and older ages (extremes)
were also associated with a lower likelihood of late ART initiation in Mozambique [8].
Lower levels of education in Uganda [13], contrarily being educated in Jimma,
Ethiopia[25] were associated with late presentation to HIV/AIDS care. In
Mozambique, High level education was associated with a lower likelihood of late ART
initiation [8] Being married or living in consensual union promotes early presentation
to care. In Uganda being unmarried [13],and similarly in Ethiopia being separated or
divorced [25] were associated with late presentation. On the other hand, being
married or in union, were associated with a lower likelihood of late ART initiation in
Mozambique [8].
Having pregnancy promotes early linkage in to HIV care cascade. Being pregnant
were associated with early presentation to care in Uganda [13] and early ART
initiation in Mozambique. In the Mozambique study; entry into care via PMTCT, year
of ART initiation were also associated with a lower likelihood of late ART initiation
[8].Rural residence is also associated with delayed care entry, increased mortality
[38] and as a barrier to accessing care in South Africa [31]
2. Behavioral determinants
Once individuals are infected with HIV, alcohol use is related to low participation in
prevention of mother-to-child transmission (PMTCT), pre-test and posttest counseling
(including returning for test results). In addition, there is a late presentation to HIV
care in patients who use alcohol heavily, compared with those who do not use
alcohol [24, 39, 40].In contrast, study from Uganda reported, heavy alcohol
consumption as incentive of lower rate of late HIV stage at presentation, with more
non-drinkers presenting late[13].Perceptions of risk for risky behaviors were reported
to affect timing of HIV care seeking. In Uganda History of causal/ Sexual partner
were associated with early presentation to care Compared to participants with no
sexual partners in the past three months [21]. Similarly, a study in Venezuela those
6reporting two partners had decreased odds of late diagnosis as compared to having
none[41].
3. Socioeconomic determinants
The association between socio-economic status (SES) and engagement in to HIV
/AIDS care is not clear. A systematic review on association between various
determinants of socio-economic status (income, education, occupation) and
adherence to ART in low- and middle-income countries reported no association. This
has been explained due to the accuracy of measuring socioeconomic status, using
only (income, education, and occupation) brings it in question [42].In single studies,
different indicators of SES were found to determine HIV care seeking behavior.
Drain, P.K., et al. reported the association of indicators like competing needs to
healthcare, non-business occupation (unemployed, farmers and with other
occupations) presented late when compared with peoples that had business
employment in South Africa [16]. Unemployement were also associated with late
presentation in Uganda [13]. Other indicators of SES had been reported to affect
presentation to HIV care such as presence and type of household water source
(those without piped water presented late versus those with piped water [13] and
Food shortage[34] The distance to the clinic and lack of time to care were reported as
barriers to care in Africa [16, 31, 34]. In south Africa, participants who lived > 5
kilometers from the test site who worked outside their home and who could not afford
medication/transport cost presented late [16] Another study in Uganda also reported
more time required to travel to clinic were a determinant of late presentation[13].
74. Social environment determinants
Presence of social support, living arrangement, and HIV status disclosure were
reported as social environment of individuals that can affect early presentation to
care. Living in a household with others was associated with late presentation to care.
In Uganda, persons  not reporting living alone presented late [13] A recent case
control study in Ethiopia observed that HIV-positive adults who lived with their
families, lived in a rented house presenting late to care[24].HIV status disclosure has
been reported as determinant of late presentation to care. Lack of spousal HIV status
disclosure were associated with late presentation to HIV care[13, 31],while having
young children were associated with early presentation to care[13].Similarly, in
Uganda having no children under age 5 and no other HIV infected household
members were associated with late presentation[13].Among HIV positives identified
by home based testing and counseling in Kenya: Having disclosed, living with
someone attending HIV care were associated with care attendance[30]. Poor
emotional health and Poor social support structures were also reported as important
risk factors for delayed HIV testing [16].In other study, Higher social support scores
were associated with earlier HIV diagnosis and timely linkage to care [43].
5. Perceived barriers
An individual’s perception of psychological costs of attending HIV treatment clinics
have been mentioned as barrier to early presentation to HIV care. Higher levels of
internalized or perceived stigma negatively impact intentions to disclose HIV status
and was associated with poor access to care [5, 11, 27, 44] , and A recent
systematic review in Sub-Saharan Africa suggests that stigma is and fears of
disclosure are important individual level deterrents to early presentation to HIV care
[34]. In Ethiopia, HIV-related stigma and low awareness were associated with late
presentation to HIV care[24]. Another study in Kilimanjaro, Kenya reported an
association of high levels of witnessed and internalized stigma with late care
seeking[29]. Fear of drug side effects had also reported to discourage timely care
seeking; patients, who perceived ART side effects, presented late to care [24].
8Drain, P.K., et al. reported long waiting times (queues) as barriers to receiving care
[16].
6. Perceived need
Anticipated or experienced benefits of attending the HIV care often promoted regular
clinic attendance. Hope of Improvements in physical well-being was reported as
promoter for seeking early care [23]. In contrast, being symptomatic as reason for
testing was associated with late HIV care seeking. Patients who tested for HIV as
result of sickness/symptoms presented late in Ethiopia [24, 25]. Late stage diagnosis
was also associated with receiving care from a non-medical facility [21, 45]. In study
conducted in Uganda, Participants who reported ever receiving care in a non-medical
setting (home, traditional healer and drug stores)  had significantly increased odds of
late stage diagnosis, compared to those who had never received care from such
providers[21] The same study indicates that, a significant proportion of HIV infected
individuals may not make contact with health facilities until late in their illness. Two
thirds of the newly diagnosed HIV infected individuals had never attended a medical
clinic at all[21]. In Kenya wanting to seek care after diagnosis were associated with
care attendance. On contrast residents who reported their current health as excellent
or who doubted their home based testing and counseling result were less likely to
report care attendance[30]. Having chronic health problems  and behavioral problems
upon HIV diagnosis were also associated with late presentation in Ethiopia [25].
A study by MacPherson, P., et al. indicated failure of linkage as multi-factorial and
negative factors at more than one level frequently interacted, having a multiplicative
effect on the risk of drop-out. Poor socio economic status, expense of clinic visits and
stigma experienced by patients towards health care providers or neighbors they know
can add up to hinder patients not to receive HIV care services[33]. A conceptual
framework for the determinants of late presentation to HIV care were adapted from
Lahuerta, Ue et al.on analysis  of determinates of late ART intention and its upstream
milestones (late diagnosis and/or late presentation to HIV care[3].The framework
includes determinants, which were found to influence late presentation to HIV/AIDS
care from previous literatures.
9Figure1.  Conceptual frame work of determinants of late presentation to HIV /AIDS
care (source: Adapted from Lahuerta, M., et al. (2013)
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1.3. Justification of the study
In the era of earlier ART initiation policies wich have been a CD4< 350 cell/mm3 yet,
and CD4 <500 cell/mm3 currently, and free accessible HIV care services, achieving
the goals’ of HIV treatment cascade requires,  factors hindering early presentation to
care are identified and tackled on.
How ever, data on determinants of late presentation when HIV care services are
accessible at local health care units is limited in Ethiopia. While late presentation to
HIV/AIDS care and its consequent attrition is a problem in the country [7, 15, 17, 18].
Identifying the determinants of late presentation to HIV care may assist in effectively
tracking the expanding HIV care services and in designing interventions to overcome
barriers to early presentation to HIV care at this level. Given Social support promoting
policies in Sub-Saharan Africa, understanding the effect of social support on early
presentation to HIV care is timely. In addition, studying the effect of using non –
medical care for the late presentation to HIV/AIDS Care, where greater than 80% of
the population uses traditional medicine is Mandatory in Ethiopia.
This study will therefore
 Establish determinants of late presentation or enrollment to HIV /AIDS care at the
‘decentralized or accessible’ setting in the era of early ART initiation Policies.
 Explore the effect of socioeconomic status, social support, use of non –medical
treatment, perceived need of HIV positives on HIV care seeking.
11
2. Objectoves
2.1. General objective:
 To identify determinants of late presentation to HIV/AIDS care among PLWHA
enrolled in HIV chronic care in Health institutions in southern zone of Tigray,
Northern Ethiopia.
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3. Methods
3.1. Study design and period:
An Institution based un-matched case control study supported with qualitative design
was conducted from March 17- April 20, 2014.
3.2. Study area
The study area is southern Tigray Zone_one of the Administrative zones of Tigray
region and it has 8 weredas 3 urban and 5 rural respectively, Maychew town is zonal
administrative town, located 645 KM north of Adiss Ababa. According to a recent
estimate of zonal administration, the total population in zone is 723,708.There are a
total 3 General hospitals, 32 health centers and 81 health posts distributed in the 8
weredas. In 2014 there were a total of 20 public health facilities providing ART
services. Currently a total of 11626 PLWHA were enrolled to HIV care out of which
8569 on –ART and 3057 Pre -ART care[46].
3.3. Source and Study population
Source population
The source population is all HIV-positive ≥ 18 years old who presented for care at
HIV chronic care clinics in the health institutions of southern Tigray zone, Northern
Ethiopia.
Study population
All People living with HIV ≥ 18 years of age that were enrolled in HIV chronic care
clinics of randomly selected 4 health centers and 2 hospitals and who come for care
during the period of data collection.
Study Units
Cases and controls were selected based on ELPCWG case definition for late
presentation by considering their base line CD4 count and/or WHO HIV/AIDS stages
at initial clinic visit. Cases were PLWHA whose CD4 count is < 350 cell/μl or WHO
stage III or IV. Controls were PLWHA whose CD4 count is ≥ 350 cell/μl and WHO
stage I or II. For the qualitative data, focus group discussions (FGD) of PLWHA who
are a member of Mother’s support group (MSG) in Mohoni health center were
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conducted. MSGs are group of HIV positive people supported by Management
Sciences for Health (MSH) and who  provide psycho-social support, adherence
counseling, promotion of facility delivery, encouragement of male involvement and
family testing, group support, family planning counseling, and promotion of
appropriate infant feeding options of  HIV positives in the community [47].
3.4. Sample size & sampling procedures
3.4.1. Sample size determination
The sample size was calculated basesd on two population proportion formula using
Epi Info version7.From previous similar study, alcohol use, denial of HIV status
disclosure to partner and perceived stigma were reported to affect early HIV care
seeking[24]. From these denial of HIV status disclosure to partner gives maximum
sample size. The following additional assumptions were considered to obtain optimal
sample size.
Proportion 46.2% for cases and 29.4 % for controls
Confidence level 95%
Power 90%
Odds ratio 2
Case control ratio 1:2
Sample size 402
Adding 10 % non response 442(147 cases and 295 controls)
3.4.2. Sampling procedures
Four health centers and 2 hospitals were randomly selected (Figure 2). At the end of
February 2014, there were a total of 9644 people living with HIV/AIDS, 7190 on- ART
and 2454 Pre -ART in these health institutions. Cases and controls were selected
using systematic random sampling based on visits during the data collection period
after equally allocating the cases and controls to the 6 health institutions. An interval
of 5 and 2 were used to select cases and controls respectively. Twelve members of
MSG (6 males and 6 females) of PLWHA were included in the focus group
discussion (FGD); Participants were selected using purposive sampling; persons who
are knowledgeable on the issue and can interact freely to get the necessary
information.
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Figure 2: Schematic representation of selection of cases and controls, Southern zone
of Tigray, February 2014
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3.5. Variables of the study
3.5.1. Dependent variable:
Late presentation to HIV/AIDS care (Case/control)
3.5.2. Independent variables:
3.5.2.1. Predisposing factors
– Socio Demographic determinants
Sex, age, marital status, pregnancy, residence, occupation,
– Behavioral determinants
Alcohol use, number of sexual partners, contact with commercial sex worker
– Knowledge about ART
3.5.2.2. Enabling factors
– Social environment determinants
House hold social support, living arrangements ,presence of  HIV care  attending
person , Presence of HIV infected household member, willingness to HIV status
disclosure, number of children age <10 years responsible,
– Perceived barriers
Stigma, fear of drug side effects, cost of transportation,
– Socioeconomic status(SES)
3.5.2.3. Perceived need
Receiving care in non-medical setting, reasons for testing on first HIV positive, hope
of improvement in well-being and desire to protect family.
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3.6. Operational definitions
Late presentation: late presentation is defined as initial presentation to care (i.e. the
first clinical visit for HIV care) with CD4 count < 350 cell/mm3 or WHO disease stage
III or IV [6].
Early presentation: is defined as initial presentation to care (i.e., the first clinical
visit for HIV care) with CD4 count ≥ 350 cell /mm3 and WHO disease stage I and II
[6].
Good Knowledge on ART: Knowledge about ART was assessed by asking 5
knowledge questions related to ART derived from related study[48].PLWHA were
said to have good knowledge on ART if he/she scored ≥ median, after summing up to
composite score.
Wealth quintiles: Socioeconomic status was measured using a wealth index for
urban and rural inhabitants separately (having private home, radio, abed with sponge
matter and a mobile phone are being common indicators for both). The index was
constructed for each household via principal components analysis (PCA).Indicators
having  greater or equal to 50% rescaled communalities were used to construct
wealth index and further categorized in to 5 wealth quintiles (as lowest, second, third,
fourth and highest based on the Ethiopian demographic and health survey (EDHS)
classification[49].
High witnessed stigma: Assessed using  5 questions  on ever encounter of  a HIV
positive  person being stigmatized by society because of his/her HIV positive Status
and persons scored ≥ median  of the sum score  have high witnessed stigma.Scale
had a Cronbach’s alpha of .63.
High Internalized stigma: Internalized Stigma was measured by using a six-item
instrument used to measure internalized stigma [50]. Each item offers a binary
(yes/no) response, and the total scale score is computed as the sum of the items.
Scale was internally consistent, with its Cronbach’s alpha of 0.82.Participants were
said to have high level of internalized stigma if they scored equal or above the
median value after summing up to composite score otherwise low stigma.
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Alcohol use: is referred as drank of alcohol 12 months prior to presenting to care
and  patients’ average daily alcohol use before attending  HIV /AIDS care were
classified as safe(1-2 drinks/day) ,at risk(3-4 drinks /day) and heavy alcohol use(5-6
drinks /day)  based on U.S. National Institute on Alcohol Abuse and Alcoholism
(NIAAA) classification.
Poor Social support: Availability of personal social support was assessed by asking
8-item social support scale questions about social support with each response rated
on a 5-point Likert scale (ranging from 1 being ‘‘none of the time’’ to 5 being ‘‘all of
the time’’). These questions incorporate two social support scales (emotional and
tangible support[51].Participants were said to have poor social support if they scored
below the median of composite score.
Perceived barriers: was assessed by recording responses to 13 lists of barriers
identified by reviewing related literatures on perceived personal barriers for receiving
HIV medical care before initiating care[23, 31, 34, 52].
Perceived need: was assessed by recording responses to 9 lists of reasons for
attending HIV care found from qualitative and quantitative studies [3, 31, 53].
Depressed: Level of depression was assessed using four-item Geriatric Depression
Scale and categorized as depressed (who scored ≥ 2) otherwise not depressed.
3.7. Inclusion and exclusion criteria
Inclusion criteria: all adult PLWHA ≥18 years of age were included.
Exclusion criteria: HIV positive persons with neither CD4 count data nor WHO
HIV/AIDS stage recorded at the first visit to the HIV care clinic and PLWHA who were
overtly cognitively impaired were excluded from the study.
3.8. Data collection tools and procedures
People living with HIV/AIDS enrolled in the selected health institutions during the
data collection period were selected based on the criteria for the cases and controls
after collecting baseline CD4 count and/or WHO staging) using chart reviews. Socio-
economic, social environment, behavioral and psychosocial determinants were
obtained from 442 eligible subjects through interviews by 11 ART nurses working in
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the HIV care clinics,using structured interviewer administered questionnaire. The
questionnaire was developed in English after reviewing relevant literatures and has
seven parts: Stage at presentation to HIV care (CD4 count and WHO clinical stages),
Socio-demographic determinants, socioeconomic status (SES), behavioral
determinants, psychosocial determinants social environment determinants and
perceived need factors.
Qualitative Data were collected by the principal investigator from one focus group
discussion (FGD). FGD were conducted using FGD guide, 2 persons_ one recorder
and one facilitator (principal investigator) participated in the data collection.FGD
session were conducted parallel to quantitive data collection and elapsed for a total
of 45 minutes.
3.9. Data quality control
The questionnaire was developed in English and it was translated into the local
language, Tigrigna. The structured questionnaire was pre - tested in 5% of the total
sample before the actual data collection in a nearby health center which were not
part of the actual study. The data were collected by ART case managers and ART
nurses.Data collectors were trained before the actual data collection.Data collection
process were supervised by principal investigator and 2 supervisors(Nurses) and
completed questionnaires were checked for their consistencies at the end of each
date of data of collection.
3.10. Data processing and analysis
Data were entered in to EPIINFO 3.5.4 and then exported in to SPSS 20 for analysis.
Data were Cleaned and coded, Descriptive analyses executed using SPSS 20, sum
and medians of composite score variables were computed. Bivariate analysis of each
independent variable with the outcome variable was conducted and variables with P
– value < 0.2 were selected for multiple logistic regression analysis. Backward LR
method was used to select independent determinants of late presentation in the
multiple logistic regressions. Odds ratio were used to measure the presence and
strengths of association and 5% level of significance was used to decide on presence
of significant association.Hosmer and Lemeshow’s goodness of fit test were used to
check fulfillment of necessary assumptions for the final model.Qualitative data were
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transcribed, translated and analyzed using thematic analysis under the sub headings
of the quantitative findings and new themes for new findings.
4.Ethical consideration
Ethical clearance was obtained from Ethical review board of Institute of public health,
University of Gondar. Letter of permission were obtained from Southern Tigray Zonal
health Bureau. Permission was sought from the respective health institutions
(medical director or persons in charge  of institutions ), to identify cases and controls
through chart review by authorized ART case managers or ART nurses. Informed
written consent after building confidentiality was also sought from each participant of
the study after their eligibility based on the chart reviews. Informed consent were
obtained from each FGD participants including concent for responses to be recorded
using audio recorder.
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5. Result
5.1. Characteristics of study Participants
5.1.1. Socio-demographic characteristics
A total of 147 cases and 266 controls were participated in this study with a response
rate of 100% and 91%, among cases and controls respectively.The median age at
time of presentation to HIV/AIDS care of PLHWA   interviewed were 30 years with
inter quartile range of 11 and 13 for cases and controls respectively (Table1).
Females account more both for cases and controls_92 (62.3%) and 180(67.7 %)
respectively. Nearly half of the cases (49.9%) and 122(45%) of controls were married
at the time of presentation to HIV/AIDS care. Eleven (12.4%) and 29(17%) of female
reproductive age (18-49) had pregnancy when they come to HIV care.  Professional
or business occupation is the highest occupation group among cases 37 (25%)
unlike farmer in controls 79(29.7). Only eighteen (12.2%) of cases and 61 (22.9%) of
controls were in the highest wealth quintile (Table 1).
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Table 1: Socio-demographic characteristics at first presentation of cases and
controls, Southern Tigray zone, Northern Ethiopia, 2014
Variables Categories Cases N (%) Controls N (%)
Sex Male 55(37.4) 86(32.3)
Female 92(62.6 ) 180(67.7)
Marital status at first
presentation
Married 73(49.7) 122(45.9)
Widowed 22(14.9) 37(13.9)
Divorced 34(23.1) 67(25.2)
Never married 18(12.2) 40(15)
Pregnancy (18-49) Yes 11(12.4) 29(17)
No 78(87.6) 141(82.9)
Education at first
presentation
Can’t read  and write 87(59.2) 167(62.8)
Primary(1-8) 40(27.2) 74(27.8)
Secondary and above 20(13.6) 25(9.4)
Residence Urban 93(63.3) 154(57.9)
Rural 54(36.7) 112(42.1)
Occupation Farmer 34(23) 79(29.7)
Professional /Business
occ. 37(25) 49(18.4)
Unemployed 25(17) 45(16.9)
House wife 27(18.4) 53(19.9)
Daily laborer 24(16.3) 40(15)
Age category 18-24 19(12.9) 63(23.7)
25-29 35(23.8) 48(18)
30-34 36(24.5) 58(21.8)
35-39 28(19) 32(12)
40-44 16(10.88) 32(12)
45+ 13(8.8) 33(12.4)
Wealth quintiles(SES) Lowest 40(27.2) 42(15.8)
Second 39(20.4) 47(17.7)
Third 24(16.3) 57(21.4)
Fourth 26(17.7) 59(22.2)
Highest 18(12.2) 61(22.9)
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5.1.2. Behavioral and Social environment conditions
Sixty six (44.9%) of cases and 126(47.4%) of controls were non drinkers 12 months
before coming to HIV care. Sixty one (41%) of cases and 76(28.8%) of controls did
not disclosed their HIV status when they present to care. Sixty two (42.2%) of cases
and 102(38.3%) of controls have < 10 years old children to look for at the time of
presentation to care (Table 2).
Table 2: Social environment and behavioral characteristics at first presentation of
cases and controls, Southern Tigray zone, Northern Ethiopia, 2014
Characteristics Cases N (%) Controls N (%)
Behavioral  Characteristics
Drinking alcohol
None users 66(44.9) 126(47.4)
Safe alcohol user 48(32.7) 85(31.9)
At risk alcohol use 29(19.7) 42(15.8)
Heavy alcohol use 4(2.7) 12(4.5)
Category of HIV transmission
Sexually 128(87) 221(83)
Using sharp needles 9(6) 27(10.2)
Caring to seek relative 7(4.7) 14(5.3)
Mother to child 3(2) 4(1.5)
Sexual Contact  with CSW
Yes 36(65.5) 45(52.3)
No 19(34.5) 41(47.7)
Social environment  determinants
Living Condition /arrangement
Alone 45(30.6) 92(34.6)
With family 46(31.3) 85(31.9)
With partner 56(38.1) 89(33.5)
Having Children < 10 years old
Yes 62(42.2) 102(38.3)
No 85(57.8) 164(61.7)
HIV status disclosure*
Not disclosed 61(41) 76(28.8)
Family member 48(32.7) 108(40.6)
Partner 26(35.6) 72(59)
Neighbors 8(5.4) 21(7.9)
For religious caregiver 6(4) 7(2.6)
Note: * % adds up more than handred % because of more than one response.
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5.1.3. Knowledge on ART, reasons for testing and use of non –medical care
Around twenty six (13.5 %) of cases as compared to 36(17.7 %) of controls haven’t
heard about ART before coming to HIV care.Sixty(40 %) of cases and 121( 45 %)
controls were tested positive during their VTC attendance.Seventy two (48.9%) of
cases   and 187(70.3%) of controls have not use any form of non medical treatment
before coming to HIV care. On contrast, a third (31.3%) of cases and 27(10.2%) of
the controls used traditional medicines for HIV before coming to care. Nearly all (91.8
%) of cases and a third quarter (74.8 %) of controls have presented to care on the
same date of their first positive test (Table 3).
Table 3: Knowledge on ART, reasons for HIV testing on first positive test , types of
non – medical care used before coming to care and time delay after testing positive,
by cases and controls in Southern Tigray zone, Northern Ethiopia, 2014
Variable Categories Cases N (%) Controls N (%)
Knowledge on
ART
Don’t heard about ART 26(13.5) 36(17.7)
Poor knowledge 71(54.4) 142(50)
Good knowledge 50(33) 88(34)
Reasons for
HIV testing
when  positive
VTC 60(40) 121(45)
Seeking care for other
disease
36(24.5) 63(23.7)
Fear of risky exposures 26(17.7) 33(2.4)
PIHCT 16(10.9) 30(11.3)
PMTCT 8(5.4) 17(6.4)
After death of spouse 1(0.7) 2(0.75)
Use of non-
medical
treatment*
None 72 (48.9) 187(70.3)
Traditional healer 46(31.7) 27(10.2)
Drug stores 27(18.4) 37(13.9)
Religious 20(13.6) 21(7.9)
Home medicines 1(0.7) 3(1.1)
Time delay
after testing
positive,
The same date 135(91.8) 199(74.8)
Within 2 years 9(6.1) 32(12)
After  2 years 3(2) 35(13)
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5.1.4. Percieved need and perceived barriers in receiving HIV care
The most frequently responded reason behind receiving HIV care were because of
severe illness among cases 126(60.5) and desire to protect family among controls
89(47.6) respectively (Figure3).
Note: Others include: coming for other services unknowingly, looking peoples testing for HIV, HIV
testing campaign, due to sickness of my spouse.
Figure 3: Perceived need to wards HIV care responded by cases and controls,
Southern Tigray zone, Northern Ethiopia, 2014
One hundred forty (52.6) of controls and 35(23.8) of cases reported no barrier in their
way to receive care. Among the list of barriers respondents perceive in receiving HIV
care, the most commonly responded barrier is fear of attending ART clinics 62(42.2)
followed by fear of stigma from the public 54(36.7) among cases, where as fear of
someone seeing when attending ART clinic 37(13.9) and fear of stigma from the
public 37(13.9) followed by fear of disclosure 40(15) were the mostly reported
barriers among controls (Figure 4).
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Fifty six (38.1%) of cases and 82 (30.8%) of controls witnessed that they observed at
least one HIV positive person stigmatized because of his /her HIV status in their
community before they first come to HIV care (Table 4). Sixty (40.8%) of cases and
132(50.3%) of controls experienced high level of internalized stigma due to their HIV
status.
Note: % doesn’t add up 100% because of more than one response, others include: fear of long
queues and don’t know where to get HIV treatment
Figure 4: Perceived barriers in receiving HIV care responded by cases and controls,
Southern Tigray zone, Northern Ethiopia, 2014
,
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5.2. Determinants of late presentation to HIV/AIDS care
On the bivariate logistic regression factors that had a P < 0.2 include, educational
status, sexual contact with commercial sex worker, internalized stigma, witnessed
stigma, depression, year of presentation to care, age category, number of life time
sexual partners, presence of HIV infected family member, living with a person
attending HIV care, level of social support, coping mechanism of first HIV positive
result, socioeconomic status and time between testing positive and receiving care.
Under the perceived need part: desire to protect my family, to know my CD4 count
and severely ill as reasons for initiating care and under the perceived barriers part:
fear of stigma and disclosure and fear of losing job or income source. Among the
above factors, sexual contact with commercial sex worker was excluded from the
final model because it doesn’t fillfull the complete cell assumption for logistic
reression (responsed by males only).
In the multiple logistic regressions, variables which were significantly associated at a
0.05 level of significance include; age groups 25-29 and 35-39, having two or more
life time sexual partners, poor socioeconomic status, no HIV status disclosure to
partner, two of the recent pairs of years of presentation, low house hold social
support; under the perceived need factors: desire to protect family and severely ill ,
under the perceived barriers category, stigma and fear of losing job or income
source(Table 4).The model were good fitting with its Hosmer and Lemeshow’s
goodness of fit test (H=0.51).
As can be seen from table 4, participants in the age group of 25-29 years were 3
times more likely to present late as compared to age group 18-24 (AOR = 3, 95 % CI:
1.15-8.12) and those in the age group of 35-39 were 4.1 times more likely to present
late as compared to age group 18-24(AOR = 4.1, 95% CI: 1.35-12.46), the other age
groups doesn’t show any significant association.
The recent subsequent pairs of years of presentation were associated with
decreased likelihood of late presentation as compared to the earliest pair (Before
2008).The risk of late presentation to HIV care among HIV positives who presented
on the year 2011-2012, and 2013-2014 decreased by 69 %( AOR =.31, 95% CI:
0.12-0.77) and 86 % (AOR = 0 .14, 95% CI: 0.05-0.37) respectively as compared to
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those presenting before the year 2008. But not significant reduction observed on the
year 2009-2010 as compared to before the year 2008(Table 4).
Presence of more than one life time sexual partners were also associated with late
presentation to HIV care. Participants with two life time sexual partners were 6 times
more likely to present late as compared with participants with no life time sexual
partner (AOR = 6 , 95% CI: 1.28-28.02). Participants with more than two life time
sexual partners were also 5.2 times more likely to present late as compared to having
none(AOR = 5.2 , 95 %CI: 1.08-24.76)(Table 4)
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Table 4. Binary and multiple Logistic regressions showing determinants of late presentation
to HIV/AIDS care, among PLWHA receiving HIV care, Southern Tigray zone, Northern
Ethiopia, 2014
Determinants
Presentation  to HIV care
COR (95% CI) AOR (95% CI)Cases (%) Control (%) P-value
Year of Presentation .000
Before 2008 37(25.2) 46(17.3) 1 1
2009-2010 62(42.2) 65(24.4) 1.2(.681-2.06) .76(.33-1.73)
2011-2012 27(18.4) 65(24.4) .51(.277- .963) .31(.12-.77)**
2013-2014 21(14.3) 90(33.8) .29(.153-.552) .14(.05-.37)**
Age category .051
18-24 19(12.9) 63(23.7) 1 1
25-29 35(23.8) 48(18) 2.4(1.23-4.73) 3.0(1.15-8.12)*
30-34 36(24.5) 58(21.8) 2.0(1.06-3.98) 1.4(.52-3.65)
35-39 28(19) 32(12) 2.9(1.41-5.96) 4.1(1.35-12.46)*
40-44 16(10.88) 32(12) 1.7(.75-3.65) 1.1(.34-3.71)
45+ 13(8.8) 33(12.4) 1.3(.62-3.29) 1.3(.37-4.23)
No. of Life time Sexual  partners
None 4(2.7) 28(10.5) 1 1 .050
One 49(33.3) 77(28.9) 4.4(1.47-13.47) 4.0(.86-18.59)
Two 46(31.3) 98(36.8) 3.3(1.08-9.9) 6.0(1.28-28.02)*
More than two 48(32.7) 61(22.9) 5.5(1.80-16.7) 5.2(1.08-24.76)*
Presence of HIV Infected member
Yes 16(10.9) 51(34.7) 1
No 131(89.1) 215(65.3) 1.9 (1.06-3.54)
Presence of HIV care  attendee
Yes 14(9.5) 44(16.5) 1
No 133(90.5) 222(83.5) 1.8(1.1 -3.56)
Witnessed stigma
low stigma 91(61.9) 184(69 .2) 1
High stigma 56(38.1) 82(30.8) 1.4(.90-2.10) 1.7(.93-3.32)
Depression
Not depressed 56(38.1) 154(57.9) 1 1
Depressed 91(61.9) 112(42.1) 2.2(1.47-3.37) 1.5 (0.82-3.0)
Level of  Social support
Poor social support 103(70) 95(35.7) 4.2(2.73-6.49) 2.3(1.26-4.30)*
Good social support 44(30) 171(64.3) 1 1
Note: * shows significant (p ≤ 0.05) & ** shows highly significantly (p < 0.001),
Underlined figures are overall p-values
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Table 4.
Continued… Presentation  to  HIV care
Factors Case (%) Control (%) COR (95% CI) AOR (95% CI) pvalue
Wealth quintile(SES) .035
Lowest 40(27.2) 42(15.8) 3.2(  1.63-6.37) 1.05(.38-2.83)
Second 39(20.4) 47(17.7) 2.8(1.43-5.52) 3.3(1.31-8.46)*
Third 24(16.3) 57(21.4) 1.4(.70-2.90) .8(.27-2.31)
Fourth 26(17.7) 59(22.2) 1.5(.74-3.0) 1.1(.44-2.82)
Highest 18(12.2) 61(22.9) 1 1
Disclosure to Partner
Yes 26(35.6) 72(59) 1 1
No 47(64.4) 50(41) 2.6(1.43-4.74) 2.0(1.05-4.14)*
HIV support groups in community
Yes 70(47.6) 150(56.4) .70(.47-1.05)
No 77(52.4) 116(43.6) 1
Diet & life style change for positive
result
Yes 49(33.3) 122(45.9) .59(.39-.89) .45(.24- .87)*
No 98(66.6) 144(54.1) 1 1
Desire to protect family
Yes 23(15.6) 126(43.4) .20(.12-.34) .19(.09 -.37)**
No 124(84.4) 140(52.6) 1 1
To know CD4 count
Yes 5(3.4) 33(12.4) .25(.095-.65) 0.37(0.09-1.43)
No 142(96.6) 233(87.6) 1 1
Severely ill
Yes 89(60.5) 66(24.8) 4.7(3.01-7.16) 4.3(2.26-8.0)**
No 58(39.5) 200(75.2) 1 1
Fear of stigma
Yes 94(63) 65(24.5) 5.5(3.5 – 8.5) 4.4(2.2-8.3)**
No 53(37) 201(75.5) 1 1
Fear of disclosure
Yes 60(40.8) 40(15) 3.9(2.43-6.23) 2.0(.99-4.32)
No 87(59.2) 226(84.9) 1 1
Fear of losing job /income source
Yes 27(18.4) 6(2.3) 9.8(3.92-24.2) 6.8(1.8-24.54)*
No 120(81.6) 260(97.7) 1 1
Note: * shows significant (p ≤ 0.05) & ** shows highly significantly (p < 0.001)
Underlined figures are overall p-values
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Socioeconomic status were also associated with late presentation, participants in the
second wealth  quintile were  3.3 times more likely to present late as compared with
the highest wealth quintile group (AOR = 3.3,95% CI:1.31-8.46). Partner or spousal
HIV status disclosure were found to deter late presentation, among married
participants those  who  do not disclosed their HIV status to their partner were 2
times those of who disclosed  to present late (AOR=2 , 95% CI : 1.05-4.14). Level of
social support were strongly associated with late presentation to care, participants
who had poor house hold social support were 2.3 times  more likely to present late as
compared to those  who had good social support  at their home (AOR=2.3 , 95% CI
1.26-4.30) (Table 4).
Barriers perceived by PLWHA were also associated with late presentation.
Participants who reported fear of stigma were 4.4 times more  likely to present late as
compared to those not (AOR = 4.4,95% CI : 2.23-8.27) and  who reported fear of
losing income source were 6.8 more likely to present late as compared to not(AOR =
6.8  ,95% CI : 1.8-24.54)(Table 4).
The way participants perceived HIV care benefits them, also attributed a discrepancy
on the stage at presentation. Participants who responded protecting family as their
reason behind initiating care were 0.81 times  less likely to present late as compared
to those not (AOR = .19, 95%CI: 0.09 -.37). On contrast, participants who responded
severe illness as a reason for initiating care were 4.3 times more likely to present late
as compared to those who responded not(AOR = 4.3, 95 % CI : 2.26-8.0)(Table 4).
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5.3. Result from Qualitative data (FGD)
Atotal of 12 PLWHA, 6 male and 6 females participated in the FGD.The age of the
participants’ ranges 27 to 55. Sex and age of participants were used to create
identification for quoted responses.
Barriers in receiving HIV care: According to the FGD participants, PLWHA delay to
care due to fear of stigma from the public and health workers they know. Expectation
of bad responses /or reaction from their relatives,hinder people not to disclose their
HIV status and public stigma discourage taking treatment or attending HIV care
clinics.Due to this no people with good income use HIV care in the nearer facility
majority of the users are the poor and rural people.
“… I was worrying about what peoples will talk about me if they hear I tested
positive”… Male-32 “When I become aware of my HIV status my challenge was fear
of health professionals and other individuals that I know while attending the ART
clinic”   Female -27.
Besides, fear of losing income source /former job, makes people cover their HIV
status and avoid taking HIV care not to be seen by their customers and work
mates.This is exacerbated by having no stable income source.In work places, people
living with HIV /AIDS are still stigmatized and considered as they are incapable of
doing their duties appropriately.
“People seem positive to HIV positives at first, but the pain  is they gradually change
their feeling and  treat  you  as ‘weak’ to accomplish your former  duty”  …HIV
positives will be shifted to lower status/position”, M ale-55
“Although they are HIV positive, numerious commercial sex workers in the town
continue their commercial sex work for the young adolescents.” Female -27
Use of non-medical treatment for HIV
As to the FGD partcipants, people try different kinds of non-medical treatments
before attending HIV care and this is associated with delayed entry to care.People
put their illness as it related to other diseases and /or ‘qole’ and try medicines from
traditional, home medicines and from drug stores.People recommend dried Wild
boar’s meat, Wild boar’s bile, Camels milk and Camels meat and other traditional
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plants as medicine for HIV.In addition people also undergo a prayer and sacrifice a
hen, a white sheep to their god or ‘qole’.
“…then she ate a dried Wild boar’s meat and Wild boar’s bile”, Female-30
“…he told me a very bitter  plant  called ‘ Oure’ or ‘Eret’ is medicine for HIV and he
have been drinking it  until he end up with death”,Female-30
“I go to a local traditional healer called ‘TonqualIi’ or magician and spend around
3000 Eth.Birr then he told to my wife wash his body using sheep’s blood and dung
added together ….”,Male-38
In addition, participants mentioned that, drugstores and pharmacies are hosts and
means of harborage for undiagnosed and purposely hiding patients with HIV, and
they use them for elongating time with out disclosing their HIV status.
“There was one HIV positive neighbor having symptoms of diarrhea, she buys drugs
from one pharmacy, she will be relived from her symptoms for some period and then
go to other pharmacy on the other day….” Female-30
“my husband were severely diseased and  confined to bed for around 6 months he
have been  telling me as his illness is due to other diseases like ,malaria,  and he has
been frequently using drugs from drug stores” Female-34
Reasons for initiating care
Protecting family is driving force behind initiating HIV care as most FGD participants
replied.
“We should let Peoples think for the generation…If my children are healthy…..”
Male -32 … “My child is negative” Female-27, “My wife and children are negative”
Males -32, 55
Many participants agreed that encouragement from one’s spouse and HIV positive
friends promotes presenting to care. When HIV positives are approached by HIV
positive counter parts this makes easier for them to be encouraged and attend care
easily.
“… I show him my ART drugs as I am taking treatment and he become persuaded to
take his treatment”, Female -55
“I become angry and decided not to take any treatment for one year. Later on my
friends were taking HIV treatment and they encouraged me to take treatment. “Male-
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Once they become aware of their status, females encourage early care including for
their spouses.Where as, males delay presenting to care once they know their status
because they think as they are healthy, but females are prone to the opportunistic
infections and they come to care as soon as they tested positive during VCT
programs.
“Males say that we are healthy even though we have the HIV and nothing bad is going
on us,but, females become ill and suffer from headache and they come to ART clinics
saying I  tested positive for HIV … ”Female -27
"….later on my wife gone to health center and tested positive after that she
encouraged me to be tested …”Male-38
“…..I then persuaded my husband to be tested for HIV and avoid taking other drugs
from outside, or drug stores’’ Female -34
As witnessed by participants, house hold and religious social support promotes early
care seeking.Religious leaders especially Priests in the Orthodox Church, persuade
their penances children to undergo HIV testing and start HIV care whenever they
disclose their status to their Priests.In other ways lack of social support is associated
with poor care seeking and adverse outcomes.
“My brother shoutes on me, you should be tested and know the cause for your illness
today; I will help every expense that follows …..”Female -35
“…she was severily ill and her family, said we don’t want to take care for the dead”
Female -27
Stage of delay to care (Late testing versus receiving care after testing)
As to the FGD participants, late presentation is after being tested positive but, not
due to late testing.Peoples are ready/ devoted/ to be tested first and to know their
HIV status but, they hide after they know their HIV status.Moreover, due to their
perception of risky exposures,people are aware of their ststus.
“The HIV testing sites that are conducted using shades in the town are always
crowded by persons being tested especially males. But, they doesn’t come to care once
tested positive [F-55]and they will be only accessed after they become diseased
through house to house tracing by volunteer HIV support groups and or they come
being carried through Stretcher or Ambulance …” Female-34
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7. Discussion
This study investigated determinants of late presentation to HIV /AIDS care when
ART services are accessible to local health units in Ethiopia. Several other studies
reported different risk factors of late presentation to care. The current study assessed
individuals perceived need to wards receiving HIV care, perceived barriers to HIV
care , socioeconomic status, the role of support groups both at house hold and
community level on late presentation.
In this study, participants aged 25-29 and 35-39 years are at increased risk of
presenting late to care as compared to younger age groups (18-24).This finding is
similar to finding in Italy[54] and Germany[37, 54].Despite age groups differences,the
general trend of increasing risk of late presentation  with age is in line with a finding in
other areas; Belgium and France in which patients aged 30-49 years were at
increased risk of “delayed presentation to care” and presentation to care with
advanced HIV disease as compared to patients aged <30 years[26], This finding is
also in line with other studies in Uganda(46 – 60 versus 16–25) years
old[13],India(35-44 and > 40 yrs as compared to 25-34 yrs)[12] and Nigeria (> 35
years versus 15-35 yrs)[35]in which older ages presented late. Another study in
Uganda also reported similar trend, participants who were 31–45 years old had 1.6
times the odds of being diagnosed late compared to participants who were 18–30
years[21]. This may be due to older ages being internally stigmatized for their
misbehaviors. However, a study in India reported against this finding, male HIV
positives aged <25 years presented late as compared to 25-35 years[36]. This may
be due to difference design, given that the Indian study was stratified by gender and
found an association only in males.
In this study, HIV positives with two or more life time sexual partners are also at
increased risk of late presentation to HIV care than those having none. This finding is
in line with the findings in South Wollo, Ethiopia in which longer time spent, or
spending 25-120 and greater than 120 months with steady partner, increased the risk
of delayed presentation to care[24] this may be due to fear of losing sexual partners.
However this finding is in contrast to findings in Uganda[21] and Venezuela [41], in
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which participants with more than one sexual partner prior to care present early as
compared to those having none. Although an increasing trend to present late the
longer a person had a steady partner were observed in Venezuela. This may be due
to the largely impeded taboos regarding sexually active behaviors in Ethiopian
context and being hiding for their wrong behaviors from their community [55].
HIV positives at second wealth quintile are at increased risk of   late presentation to
HIV care as compared with highest wealth quintile. A systematic review on three
indicators of socio economic status (education, income and occupation) documented
lack of association of socioeconomic status with adherence to ART in low- and
middle-income countries [42]. However, a study in Uganda[13] reported association
of late presentation with some socio-economic variables separately. Another study in
Ethiopia reported a direct association between living in rented house and late
presentation. Findings from Durban, South Africa also documented association
between goings without health care because needed money for food, clothing, or
housing and Presentation with late-stage HIV disease[16]. The finding of the present
study adds up the previous findings by incorporating additional variables of
socioeconomic status and identifying its effect on HIV care receiving behavior of HIV
positives.
Among the social environment determinants, HIV status disclosure to partner and
house hold social support were associated with late presentation to HIV care.
PLWHA with poor social support are at an increased risk of late presentation as
compared with those having good social support. The qualitative data also enrichs
this finding; house hold support and support from friends improving timely care
seeking. This is in line with finding in Durban, South Africa [16]and other study in
Africa[43].This may be due to, feeling less encouraged and not being supported may
affect HIV positives not to disclose their HIV status and tell their relatives about HIV
care.Participants who do not disclose their HIV status to their partner are at
increased odds of late presentation as compared with those who do. This finding is in
line with studies in Uganda[13],Kenya[30]and Ethiopia[24].This may be due to the
unprecedented  support  following disclosing ones status.
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HIV positives presenting on the recent years of presentation are at decreased risks of
late presentation as compared before the year 2008.This is in line with findings in
Nigeria[35],Belgium and France[26], New York City[56] and India[36].This may be
due to the increasing access, awareness and reduction in stigma through time[52,
57, 58]
Fear of stigma and fear of losing job /income source are barriers perceived by
PLWHA associated with late presentation in this study.Participants who dread of
stigma are at increased risk of late presentstion as compared to not and participants
who fear  losing job /income source are at increased risk of presenting late as
compared to those  not.This is also supported by the qualitative data with public
stigma and losing income the mainly reported barriers.The finding on Stigma is in line
with systematic review conducted in sub Saharan Africa, which documented stigma
and fear of disclosure as main reported barriers [34].The finding on fear of losing
income source as barrier behind receiving HIV care is similar with findings of
systematic review in Africa[34]and study in Zimbabwe [59] ,in which, being poor and
uninsured were connected with lack of medical care for those with AIDS. Similarly,
financial barriers were reported from South Africa although service delivery, structural
barriers are prevailing [16].This may be due to, losing their income source or due to
losing of customers from the underlining stigma.
In the present study, participants initiating care as the result of severe illness are at
increased risk of late presentation where as those due to their desire to protect family
are at decreased odds of late presentation as compared to none.This is witnessed by
qualitative data, in which protecting family and children were driving the need to
initiating HIV care. The finding for severe illness as reason is similar with finding of
systematic review [34] in which perceived poor health predicted retention to care.
Unfortunately this is also associated with increased risk of late presentation, in the
present study. The documented association between being symptomatic during
presentation to care and late presentation in Ethiopia [24, 25] is related to this
finding. There are no quantitative studies that measured the association between
perceived need and presentation to care, but qualitative studies documented on the
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association between patients desire to protect family and timely care seeking[23, 31,
53].
There is no significant association between use of non-medical treatment and sex of
respondent with late presentation both in the bivariate and multiple logistic
regressions. However, results from the FGD indicate that males and non –medical
treatment users present late for HIV care. This may be due to, respondents may not
tell their use of other medicines correctly.
Unlike to finding in Jimma, Ethiopia[25] there is no significant associaition between
time from testing positive to presenting to care with late presentation.How ever,
results from the FGD, indicate that HIV positives stay long time after testing positive
with out reciving care.This difference may be due to exact first positive dates may n’t
be recorded correctly.
This study has also incorporated variables significant in previous studies like;
presence of HIV care attending person, depression, presence of HIV infected house
hold member, presence of HIV support groups in the community and witnessed
stigma. However, these variables were only significant in the bivariate analysis but
not in the Multiple logistic regression. This may be due to the difference in setting
given that this study is conducted mainly at health centers.
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8. Strengths and Limitations of the study
Strengths of the study
As strengths this study incorporated diverse determinant factors, meeasured
socioeconomic status using wealth index and conceptualized determinants based on
established model.
Limitation of the study
The study may be prone to recall bias and some variables difficult to measure
accurately.
Selecting HIV positives only recently enrolled to care were not done ⇨ Dealing the
current scene were impossible.
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9. Conclusion
This study identified, in this study , independent determinants of late presentation in
local health center setting, where HIV care services are accessible at local heath
service outlets. These determinants can be categorized under broader domains of
determinant factors including : demographic(age group), social environment( HIV
status disclosure,socialsupport),behavioral(life time sexual partners),
economic(socioeconomic status ), perceived barriers (fear of stigma and fear of
losing income source) and perceived need(desire to protect family and due to severe
illness).
Findings from the FGD also showed that, male sex, use of non-medical treatment,
fear of losing/transferring from best jobs, and fear of stigma are the factors that make
HIV positives to present late.On contrast, encouragement from HIV positive friends
and spouse (female partners) and support from other family members and religious
leaders (especially to their penance children) promote early care seeking.
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10.Recommendations
To HIV control and prevention offices
It is better to
– Strengthen involvement of, females and HIV positives in early care seeking
efforts.
– It is better to work place discrimination be sensitized in public and private
organizations.
To Heath educators
It is better to
– To implement interventions on building the perceived needs of HIV positives to
wards HIV care.
– To implement behavioral interventions targeting; males, young adults and
sexually active sections of society.
– Educate on wrong perceptions and myths of people on HIV cure.
To providers at pharmacies, drug stores & traditional healers
– Better to advice people to seek additional services including HIV testing at
medical facilities
To Researchers
– Researches should be conducted on unmeet needs of HIV positives  that  affect
care seeking
– Additional research should be conducted prospectively on newly presenting HIV
positives
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12. Annexes
Annex I:  Information sheet
Title of the Research Project
Determinants of Late Presentation to HIV/AIDS Care among People living with
HIV/AIDS enrolled in HIV chronic care clinics in Southern Tigray zone, Northern
Ethiopia: Institution based un-matched Case Control Study
Name of Principal Investigator: Goitom Halefom (BSc)
Name of Advisors:
1. Ato Akilew Awoke (BSc,MPH)
2. Ato Yalemzewd Assefa (BSc,MPH)
Name of the Organization: Institute of Public Health, College of Medicine and
Health Sciences, University of Gondar
Name of the Sponsor: University of Gondar
Introduction
This information sheet is prepared with the aim of explaining about the
research project that you are asked to join by the group of research
investigators. The research group includes one main principal investigator,
six trained data collectors and two advisors from University of Gondar.
Purpose of the research project
The purpose of this project is to identify determinants of late presentation to
HIV/AIDS care among people living with HIV/AIDS enrolled in ART clinics in
health institutions in Southern zone of Tigray, Northern Ethiopia.
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Procedure
The study mainly uses data obtained through chart review and study subject’s
interview .Permission was obtained from University of Gondar, Southern Tigay zonal
health department, the selected health institutions and  as well as study subjects.
Risk and/or Discomfort
By participating in this research project you will not feel any discomfort except
wasting some time (around 40 minutes). There is no risk in participating in this
research.
Benefits
There is no direct benefit for your involvement in the study, but your participation is
necessary for the accomplishment of the study purpose and indirectly you will be
benefited from research outcome in reducing delays to care seeking by identifying
reasons for delays of people living with HIV/AIDS.
Confidentiality
Your information is confidential and your name is not written on the questionnaire
only data for what you are going to be interviewed are utilized for the research
purpose.Information will be stored in a file and kept without your name, but a code
number assigned to it. And it will not be accessed by anyone except the principal
investigator.
Right to Refusal or Withdrawal
Your participation in this research study is voluntary. You may choose not to
participate and you may withdraw your consent to participate at any time without
losing any of your right.
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Persons to contact
This research project was reviewed and approved by the Ethical review board of
Institute of Public Health, University of Gondar. If you have any questions or
concerns about this study please contact the following individuals:-
Advisors:
1. Ato Akilew  Awoke ; Institute of Public Health, CMHS, University of Gondar Phone
no: +251-918-03-53-92,email:akilew24@gmail.com,
2. Ato Yalemzewod Assefa; Institute of Public Health, CMHS, University of Gondar
Phone no: +251-911-56-84-77, email:pipizewa@gmail.com,
Principal Investigator:
1. Goitom Halefom
Phone no: +251-928-34-80-52/+251-912-87-09-01 , email:aboabuye@gmail.com,
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Annex II: Consent Form
Interviewer: Welcome! My name is ------------------------------------------------------------ I
am working here in this hospital /Health center as ART Nurse. You are required here
for interview for a research conducted by Ato Goitom Halefom Senbete a master’s
degeree student in University of Gondar, on determinants of late presentation to HIV
/AIDS care among People living with HIV/AIDS in Southern zone of Tigray. You were
included as participant for interview because you are selected randomly. You will be
asked a series of questions for around 35 minutes. Your data is confidential and your
name will not be written on the questionnaire only data for what you are going to be
interviewed are utilized for the research. Participation to the study is voluntarily.
There is no direct benefit for your involvement or no cost for your not involvement in
the study, but your participation is necessary for the accomplishment of the study
purpose.
Interviewer: Are you voluntary to participate?
Participant: 1. Yes 2. No,
Interviewer: Thank You, your consent and
signature please.
Thank You, you can go
Participant:
I understand fully the benefit of the
study absence of any risks on me and
I hereby approve my consent to take
part in the study with my signature
signature____________________
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ANNEX III: Questionnaire
1. Health Facility Name ________________________________
2. Code number (Health Facility Name/001 …)_________________________
S.NO Questions Response Remark
A From records review in chart: both fields should be filled the results of initial
visit of the patient.
Code Part I: Stage at First Presentation to
HIV/AIDS  care
If initial  CD4
and WHO
stage are
absent
do not
Interview
The  patient
101 Year of presentation /enrollment to HIV
care
______/______/_______ E.C
102 CD4 count at First
enrollment/presentation to HIV/care ________________________Cell/
mm3
103 WHO HIV/AIDS clinical stage at First
presentation/ enrollment in to HIV/AIDS
care
1. Stage I
2. Stage II
3. Stage III
4. Stage IV
B. For Interview: All Questions Are intended to measure the aspects of the patient before coming
to the HIV care clinic for the first time. So questions should be asked as stated in the
questionnaire or all questions should be asked by stating before coming to HIV care for the
first time…..
Code PART II: Socio-demographic  characteristics
201 Sex 1. Male                        2. Female
202 Age at first presentation __________    years
203 Marital status at presentation to care 1. Never married
2. Married
3. widowed,
4. separated/divorced
204 Presence of Pregnancy at presentation 1. Pregnant   2. not pregnant If  101
Female
205 Educational level at presentation 1. Can’t read /write
2. Primary(1-8)
3. Secondary(9-12)
4. University /college
206 Residence 1. Urban       2. Rural
207 Occupation 1. Student
2. House wife
3. Government employee
4. Private sector employee
5. Trader
6. Farmer
7. Daily laborer
8. Unemployed
9. Sex workers
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Code PART II: Perceived  need Response Remark
301 When did know you positive HIV status for
the first time? ------/-------/---------
302 Where did you tested HIV positive for the first
time
1. At this health facility
2. Other ( specify) ----------
303 When you tested positive What where our
reason for testing for HIV
1. VTC ,
2. PIHCT ,
3. PMTCT,
4. Self-initiative/Fear of risky
exposures
5. Seeking care for other disease
304 How do you contract HIV /AIDS? 1. When caring to seek
parent/relative
2. Sexual transmission
3. Using sharp materials
4. Others(specify)
305 What initiated you to start HIV care? 1. Desire to protect baby, self and
family
2. To know CD4 count and begin
HIV treatment when needed
3. Encouragement from partner,
friend, work mate or family
member
4. Not healing using other options
5. severely ill
6. Fear of severity of
disease/death from HIV
7. Hope of Feeling better/well
after taking ART
8. I know taking HIV treatment is
must
9. Don’t know
10.Others (specify)
307 Had you received any treatment/care for HIV
in non-medical setting before coming here?
1. Yes       2. No
308 If yes for 307 from which type of facility do
you seek care?
1. Traditional healer
2. Drug stores,
3. Home  medicines
4. Religious (tsebel)
5. Others( specify
More
than
one
possi
ble
Code PART IV : Knowledge about Antiretroviral
treatment (ART)
Response Remark
401 Have you heard about ART before coming to
this facility?
1. Yes        2. No If  2 go to
part V
403 Do you know either of the following before
you start HIV care?
ART is obtained free of charge from hospital 1. Yes      2. No
ART can prolong life 1. Yes      2. No
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ART is life-long treatment 1. Yes      2. No
ART is used only when someone is very ill 1. Yes      2. No
An HIV-infected pregnant woman can be
treated with ART
1. Yes      2. No
ART reduces levels of HIV virus in the body 1. Yes      2. No
Code PART V: Perceived health service delivery
barriers
Response Remark
501 Was there any factor you hindered from
using HIV care before?
1. Yes   2. No If 2  go to
Part 503
502 Which one of these challenges (factors)
hindered you from using care?
1. ART Service given by persons
that I know
2. Lack of money for
transportation
3. HIV clinics not opened at
convenient times
4. Fear of someone finding/seeing
me when I attend ART clinics
5. Fear of marital Relationship
strains /or partner violence
6. Fear of losing job or/income
source
7. Fear of side effects of drugs
8. Fear of disclosure
9. Fear of Stigma from the public
10.Partner controlling finances
11.Fear of Long Queues,
12.Long distance (long )travel time
13.Don’t know where to get HIV
treatment
14.Other(specify)
More
than
one
respo
nse
possi
ble
503 How far is your home from your nearer HIV
care clinic?
_____ in kilometers
--------hrs of walk on  foot
Code PART V:Behavioral  factors Response Remark
601 Do you drink alcohol 1. Yes     2. No
602 How many drinks do you have on average
day? 1. 1-2 drinks/day
2. 3-4 drinks /day
3. 5-6 drinks /day
603 How many steady relationships have you
ever had?
1. One
2. Two
3. More than two
604 Had you have sexual contact with
commercial sex worker before you come to
care?
1. Yes
2. No
Code PART VII : Social environment  determinants Response Remark
701 With whom were you living when you come
to HIV care first?
1. Alone
2. With family
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3. With partner
702 Had there HIV infected household/family
member when you come to treatment?
1. Yes                   2. No
703 Was there some body living with you
attending HIV care?
1. Yes                        2.  NO
704 Had you have children < 10 years to look for
when you come to care?
1. Yes   2. No
705 When you come to care, had you disclosed
your HIV status
1. Yes    2. No
706 If yes 705 to which of the following did you
disclosed your status?
1. Partner
2. Family member
3. Neighbors
4. For religious  care giver
707 When you become aware of your HIV status
first, what mechanisms did you used to cope
your newly?
1. Seek advice /support from
Partner, Family or Spiritual care
giver
2. Seek Traditional medicines
3. Changed my diet and  life style
4. Keep my status secrete
Code Social support scale Response (None of the
time(NT),Sometimes(ST), A lot of
times (LT),Nearly all of the
times(NAT) , All of the times (AT)
Remark
708 If you needed it, how often is someone
available?
To help you if you were confined to bed? 1. NT 2.  ST   3. LT 4. NAT 5. AT
To take you to the doctor if you need it? 1. NT 2.  ST 3. LT 4. NAT  5. AT
To prepare your meals if you are unable to
do it yourself?
1. NT 2. ST 3. LT   4. NAT  5. AT
To help with daily chores if you were sick? 1. NT 2.  ST  3. LT 4. NAT 5. AT
To have a good time with? 1. NT   2.  ST 3. LT 4. NAT 5. AT
To turn to for suggestions about how to deal
with a personal problem?
1. NT  2.  ST 3. LT 4. NAT 5. AT
Who understand your problems? 1. NT   2.  ST 3. LT 4. NAT5.AT
To love and make you feel wanted? 1. NT   2.  ST 3. LT 4. NAT 5. AT
Code Depression Scale Response
709 Are you basically satisfied with your life? 1. Yes 2. No
Do you feel that your life is empty? 1. Yes 2. No
Are you afraid that something bad is going to
happen to you?
1. Yes 2.No
Do you feel happy most of the time? 1. Yes 2. No
Code Internalized stigma scale Response Remark
710 Do you agree with one of the following
It is difficult to tell people about my HIV
infection
1. Yes    2. No
Being HIV positive makes me feel dirty 1. Yes    2. No
I feel guilty that I am HIV positive 1. Yes    2. No
I am ashamed that I am HIV positive 1. Yes    2. No
I sometimes feel worthless because I am HIV 1. Yes    2. No
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positive
I hide my HIV status from others 1. Yes    2. No
It is difficult to tell people about my HIV
infection
1. Yes    2. No
Being HIV positive makes me feel dirty 1. Yes    2. No
Part VIII: Community level determinants Response
Code Presence of community support groups 1. Yes 2. No
801 Are there HIV support group working on
HIV/AIDS in your community?
1. Yes 2. No
802 IF yes For  801 what type of support groups 1. Community support groups
2. Religious supports
3. HIV support groups,
Code Witnessed stigma/Discrimination in
community
Response
803 Do you know someone who has had the
following happen to him/her because of HIV
infection?
Lost customers to buy his/her produce/goods
or lost a job.
1. Yes 2. No
Abandoned by spouse/partner or family. 1. Yes 2. No
Teased or sworn at. 1. Yes 2. No
Physically abused 1. Yes 2. No
Lost respect/standing within the family and/or
community.
2. Yes 2. No
Code Part VII: Wealth index of households related
questions
response Remark
911 A. For urban inhabitants If 206
urban
Private home 1. YES    2. NO
Electric city 1. YES    2. NO
A radio 1. YES    2. NO
A Television 1. YES    2. NO
A Mobile telephone 1. YES    2. NO
A Non-mobile telephone 1. YES    2. NO
A Refrigerator 1. YES    2. NO
A table 1. YES    2. NO
A chair 1. YES    2. NO
A bed with cotton/ sponge/spring matters 1. YES    2. NO
An electric mittad 1. YES    2. NO
912 B. For Rural inhabitants If 206
Rural
private home 1. Yes    2. No
A radio 1. Yes     2. No
A mobile telephone 1. Yes      2. No
A bed with cotton/ sponge/spring matters 1. Yes      2. No
A kerosene lamp/pressure lamp 1. Yes   2. No
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ANNEX IV: FGD Guide
1. What are the reasons for HIV positives not to come to Care early?
2. What options / medicines do HIV positive people use other than ART?
3. At what stages of  HIV care  cascade do people become late
a. At testing?
b. At receiving care after being aware of HIV positive?
4. Which group of people presents late to care?
5. What community level factors
a. Encourage people to start HIV care?
b. Discourage people not to start HIV care?
6. What are the barriers HIV positives perceive in receiving HIV care?
7. What should be done for people not to late?
Annual farm product per quintal _____________________quintal
How many (local units) of agricultural land do
you own
________________in number
How money of the following domestic animal
does your household own?
Milk cows, oxen or bulls ______________in number
Horses, donkeys, or mules ______________ in number
Goats? ______________ in Number
Sheep? ______________ in Number
Chickens? ______________ in number
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ANNEX V: Tigrigna version queistionnaire
1. ብዛዕባ አዚ መፅናዕቲ ዝገልፅ ሓበሬይታ /መረዳእታ መውሃቢ ወረቀት
ናይቲ መፅናዕቲ ርዕሲ
አብ ዞባ ደቡብ ትግራይ አብ ዘለዉ ትካላት ጥዕና ዘለዉ ናይ ፀረ-ኤች.አይ.ቪ ኤድስ መድሓኒት ተጠቀምቲ
መጀመርያ ሕክምና ንምርካብ ዘንጊዖም ናብ ሕክምና ክአትዉ ዝገብሩዎም ምክንያታት
ዋና ተመራማሪ ፡ ጎይቶም ሓለፎም (BSc)
አማኸርቲ
3. አይተ አቅለው አወቀ (BSc,MPH)
4. አይተ ያለምዘውድ አሰፋ (BSc,MPH)
ሽም ዩኒቨርሰቲ ፡ ጎንደር ዩኒቨርሰቲ ናይ ሕክምናን ጥዕና ሳይንስን ኮሌጅ ፣ ናይ ሕብረተሰብ ሓለዋ ጥዕና
ኢንሰቲቱት
ናይቲ መፅናዕቲ ወፃኢ ዝሽፍኖ አካል፡ ጎንደር ዩኒቨርስቲ
1. መእተዊ ፡-
እዚ ሐበሬታ መውሃቢ ወረቀት ዝተዳለወ ብዛዕባ አዚ እትሳተፎ /ዮ መፅናዕቲ ገለፃ ንምግባር እዩ
፡፡ እዚ መፅናዕቲ ብጉጅለ መፅናዕቲ ዘካይዱ አካላት ዝካየድ እንትኸውን አቲ መፅናዕቲ መካየዲ
ጉጅለ ካዓ እዞም ዝስዕቡ አካላት ዝሓዘ እዩ፡፡ ሓደ ዋና ተመራማሪ፣ሽዱሽተ ዝሰልጠኑ መረዳታ
አከብቲ(ነርስ) ን ክልተ አማኸርቲ ከዓ ካብ ጎንደር ዩኒቨርሰቲ ፡፡
2. ዓላማ ናይቲ መፅናዕቲ፡-
አብ ዞባ ደቡብ ትግራይ አብ ዘለዉ ትካላት ጥዕና ዘለዉ ናይ ፀረ-ኤች.አይ.ቪ ኤድስ መድሓኒት
ተጠቀምቲ መጀመርያ ሕክምና ንምርካብ ዘንጊዖም ናብ ሕክምና ክአትዉ ዝገብሩዎም ምክንያታት
ንምፅናዕ እዩ፡፡
3. እቲ መፅናዕቲ ዝካየደሉ መንገዲ፡-
እዚ መፅናዕቲ ዝካየደሉ ብመጀመርያ ደረጃ ንተሳተፍቲ ብዝግበር ቃለ መጠይቕ ኮይኑ እዚ መጽናዕቲ
ንምክያድ ካብ ጎንደር ዩኒቨርስቲ ናይ መጽናዕቲ ስነ ምግባር ቦርድ አፍልጦ ተዋሂቡዎ፣ ካብ ቢሮ ሓለዋ
ጥዕና ዞባ ድቡብ ትግራይን አቶም ዝተመረጹ ጥዕና ትካላትን ፍቃድ ተዋሂቡዎ እዩ፡፡
4. አብ መፅናዕቱ ብምስታፍ ዘስዕቦ ጉድአት /ሳዕቤን/፡-
አብዚ መፅናዕቲ ብምስታፍካ/ኪ ንቃለ መሕትት ካብ እተጥፍኦ/ዮ 30-40 ደቒቓ ወጻኢ ምንም ዓይነት
ዝበፅሓካ/ኪ ጸገም ወይ ከዓ ሓደጋ የለን፡፡
5. ናይዚ መፅናዕቲ ረብሓ/ጥቅሚ ፡-
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አብዚ መፅናዕቲ ብምስታፍካ/ኪ ንስካ ቀጥታ እትጥቀሞ ጥቅሚ ዘይክህልው ይክእል እዩ፡፡ ነገር ግን
ናትካ ተሳትፍ ሰባት ናብ ኤች.አይ.ቪ ኤድስ ሕክምና ቀልጢፎም ንከይጅምሩ ዝገብርዎም
ምክንያታት አብ ምፍላይን መጻኢ ወለዶ አብ ምድሓንን ዓብዪ እጃም አለዎ፡፡ ስለዚ ብተዘዋዋሪ
መጻኢ ወለዶ ብምድሓን ተጠቃሚ ኢካ ማለት እዩ፡፡
6. ናይ መረዳእታ ምስጥራዊነት ፡-
ነዚ መፅናዕቲ እትህቦ ዝኮነ ይኩን መረዳእታ ብምሰጢር ዝተሓለወ እዩ፡፡ ብመጀመርያ ሽምካ አብዚ ወረቀት
አይፅሓፍን ፣እዚ ዝእከብ መረዳእታ ጥራሕ ነዚ መፅናዕቲ አገልግሎት ይውዕል፡፡ ምስተአከበን ነቲ መፅናቲ
አገልግሎት ምስ ውዓለን እቲ ወረቀት ተቆሊፉ ሰብ አብ ዘየግንዮ ቦታ ይቕመጥ፡፡
7. አብዚ መፅናዕቲ ናይ ዘይምስታፍ መስል፡-
አብዚ መፅናዕቲ ምስታፍካ አብ ፈቓደኛነት ዝተመስረተ እዩ፡፡ ምስታፍ ተዘይደሊካ እቲ ቃለ
መጠይቅ ምሰተጀመረ ኮነ ቅድሚ ምጅማሩ ዘይምስምዕማዕ ይካአል እዩ፡፡
8. ንዝበለፀ ሓበሬታ፡-
አዚ ናይ መጽናዕቲ መደብ ብ ናይ ጎንደር ዩኒርሲቲ ምርምር ስነ-ምግባር ኮሚቴ ተገምጊሙ ዝጸደቐ አዩ፡፡
ብዛዕባ እዚ መጽናዕቲ ዝኮነ ይኩን ዓይነት ሕቶ ወይ ከዓ ሐሳብ እንተሃልዩኩም ነዞም ዝስዕቡ አካላት
ደውልኩም ምርካብ ትኽእሉ እኹም፡፡
አማኸርቲ
ናይ አማኸርቲ አድራሻ
1. አይተ አቅለው አወቀ (BSc,MPH)፡ ጎንደር ዩኒቨርሰቲ ናይ ሕክምናን ጥዕና ሳይንስን ኮሌጅ ፣ ናይ
ሕብረተሰብ ሓለዋ ጥዕና ኢንሰቲቱት፡ ስልኪ ቑፅሪ: +251-918-03-53-92,ኢ -ሜይል :
akilew24@gmail.com
2. አይተ ያለምዘውድ አሰፋ (BSc,MPH)፡ ጎንደር ዩኒቨርሰቲ ናይ ሕክምናን ጥዕና ሳይንስን ኮሌጅ ፣ ናይ
ሕብረተሰብ ሓለዋ ጥዕና ኢንሰቲቱት፡ ስልኪ ቑፅሪ: +251-911-56-84-77, ኢ -ሜይል :
pipizewa@gmail.com
ዋና ተመራማሪ ፡
3. ጎይቶም ሓለፎም (BSc) ስልኪ ቑፅሪ: +251-928-34-80-52,
ኢ -ሜይል: aboabuye@gmail.com
1. ውዕሊ ስምምዕነት መምለኢ ፎርሚ
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ሐታቲ፡ ሰላም ከመይ አለካ/ኪ? ሽመይ --------------------------------------- ይብሃል ብሞያይ------------------------
- እየ፡፡ አብዚ ሆስፒታል /ጥ/ጣብያ ናይ ኤች .አይ . ቪ. ኤድስ ሕክምናን ክንክንን አገልግሎት ሰራሕተኛ
እየ፡፡ሐዚ ንዓካ /ኪ ዝደለናሉ ምክንያት አብ ጎንደር ዩኒቨርሰቲ ናይ 2ይ ድግሪ ተምሃራይ ዝኮነ አይተ ጎይቶም
ሐለፎም አብ ዞባ ደቡብ ትግራይ አብ ዘለዉ ትካላት ጥዕና ዘለዉ ናይ ፀረ-ኤች.አይ.ቪ ኤድስ መድሓኒት
ተጠቀምቲ መጅመርያ ሕክምና ንርካብ ንምነታይ ዘንጊዖም ናብ ሕክምና ከም ዝአትዉ ንዝግበር መፅናዕቲ
ንክትሳተፍ እዩ፡፡ ንስካ ዝተመረፅካሉ ብዕጫ ኮይኑ እቲ መፅናዕቲ ዝደልዮ ረቑሓ ስለ እተማልእ እዩ፡፡ አብ
መፅናዕቱ ምስታፍ አብ ፈቓደኝነት ዝተመርኮዘ እዩ፡፡ ምስታፍ ዘይምስታፍ ይከአል፣ቓለ መጠይቕ
ምስተጀመረ ኮነ ቕድሚ ምጅማሩ ተዘይተሰማዕሚዕካ ምቁራፅ ይከአል እዩ፡፡አብ መፅናዕቱ ብምስታፍካ ንኣካ
ምንም ዓይነት ጥቕሚ ወይ ከዓ ፅልዋ የብሉን ነገር ግን ነቲ መፅናዕቲ ዓለማ ብጣዕሚ ወሳኒ ግደ አለዎ፡፡
ካባካ ዝውሰድ መረዳእታ ምስጥሩ ዝተሓለወ አዩ፡፡ሽምካ አብዚ ወረቀት ስለ ዘይፅሓፍ ምሳካ ብምንም
ምክንያት አይትሓሓዝን፡፡ አቲ መረዳእታ ነዚ መፅናዕቲ ምስ ወዓለ ሰብ አብ ዘየግንዮ ተቆሊፍ ይቕመጥ፡፡
ሐታቲ ፡ ስለዚ ንክትሳተፍ ፍቓደኛ ድኻ ?
ተሳታፊ፡ 1. እወ 2. አይኮንኩን
ሐታቲ፡ ብጣዕሚ የመስግን ብጣዕሚ የመስግን ምካድ ትክእል እካ/ኪ
ተሳታፊ፡ ናይቲ መፅናዕቲ ዓላማን አብ አይ ምንም
ዓይነት ጉድአት ዘይብሉ ምካኑን ብግልፂ
ተረድአ ንምሰታፍ ፍቓደኛ ምኻነይ የረጋግፅ
ፊርማ-----------------------------------
2. መጠይቕ
ናይቲ ጥዕና ትካል ሽም -----------------------------------------------------------------
ንተሓታቲ ዝውሃብ መፍለይ ቑፅሪ -------------------------------------------------------------
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ሀ. ናይ ተሳታፊ መዝገብ ብምርአይ ዝምላእ ፡ ካብ 101-103 ዘለዉ ሕቶታት አቲ ተሳታፊ መጀምርያ ናብ
ኤች.አይ.ቪ ኤድስ ክንክን አብ ዝመፅአሉ ጊዜ ዘሎ መረዳእታ ጥራሕ ክምላእ አለዎ፡፡
ሕቶ ነቲ ሕቶ ዝተውሃበ መልሲ መብርሂ
መ.
ቑ
1ይ ክፋል፡ መጀመርያ ናብ ኤችአይቪ ኤድስ ክንክን አብ ዝመፅእሉ ጊዜ ዝነበረ ናይቲ ሕማም ደረጃ ዝገልፅ
መረዳእታ
CD4 ቁጽሪን
ናይትካል ጥዕና
ዓለም ደረጃን
ዘይፍለጥ/ዘይተመ
ዝገበ እንተኮይኑ
እቲ ተሳታፊ ቃለ
መጠይቕ ምግባር
አየድላዪን
101 መጀመርያ ናብ ኤችአይቪ ኤድስ ክንክንን ህክምናን
ዝመፅአሉ/ትሉ ዓመት ______/______/_______ ዓ.ም
102 መጀመርያ ናብ ኤችአይቪ ኤድስ ክንክን አብ
ዝመፅእሉ ጊዜ ዝነበረ ቁፅሪ CD4 ____________________ዋህዮ/ሚሜ3
103 መጀመርያ ናብ ኤች.አይ.ቪ ኤድስ ክንክን አብ
ዝመፅአሉ/ትሉ ጊዜ ብትካል ጥዕና ዓለም / WHO
/ዝነበረ ናይቲ ሕማም ደረጃ
5. ደረጃ I
6. ደረጃ II
7. ደረጃ III
8. ደረጃ IV
ለ. ብቓለ መጠይ ቕ ዝምላእ፡ ኩሎም ሕቶታት ናይቲ ተሳተፊ ቅድሚ ናብ ኤች.አይ.ቪ ኤድስ ክንክን ምምፃኡ ዝነበሮ ኩነታት
ንምዕቃን ተደልዩ ዝተዳለዉ እዮም፡፡ስለዚ ኩሎም ሕቶታት ከምቲ ተፃሕፎምዎ ዘለዉ ወይ ከዓ ቕድሚ መጀመርያ ናብ
ሕክምና ምምፃእካ…. ተባሂሉ ክሕተት አለዎ፡፡
መ.
ቑ
2ይ ክፋል : ማሕበራዊን ስነ-ህዝቢባዊን ኩነታት ነቲ ሕቶ ዝተውሃበ መልሲ መብርሂ
201 ፆታ 2. ተባ 2. ኣነ
202 መጀመርያ ናብ ኤች.አይ.ቪ ሕክምና አብ ዝመፃእካሉ /ክሉ
ዕድመካ ክንደይ ነይሩ? __________ ዓመት
203 መጀመርያ ናብ ኤች.አይ.ቪ ሕክምና አብ ዝመፃእካሉ ጊዜ
ናይ ሓዳር ኩነታትኪ/ካ ከመይ ነይሩ ?
5. ዘይምርዕው
6. ዝተመርዓወ/ወት
7. ሰብአያ /ሰበይቱ ዝሞታ/ተቶ
8. ዝፈትሐ/ዝፈትሐት
9. ካሊእ(ይገለፅ)
204 መጀመርያ ንኤች.አይ.ቪ ክንክን አብ እትመፅእሉ ጊዜ ፅንሲ
ነይሪኪ ዶ ?
1. እወ 2. አይነበረንን 201 ኣነ
205 መጀመርያ ንኤች.አይ.ቪ ክንክን አብ እትመፅእሉ/አሉ ጊዜ
ደረጃ ትምህርቲ ?
5. ምንባብ/ ምፅሓፍ ዘይኽእል)
6. 1ይብርኪ(1-8)
7. 2ይብርኪ (9-12)
8. ካብ ዩኒቨርሰቲ/ኮሌጅ ንላዕሊ
206 እትነብረሉ/ርሉ ቦታ 2. ከተማ 2. ገጠር
207 ስራሕካ/ኪ እንታይ ነይሩ ? 10. ተምሃሪት/ራይ
11. ናይገዛ እመቤት/ብዓልቲ ቤት/
12. ሰራሕተኛ መንግስቲ
13. ናይ ግሊ ትካል ሰራሕተኛ
14. ነጋዳይ
15. ሐረስታይ
16. መዓልታዊ ሰራሕተኛ
17. ሰራሕ ዘይብሉ
18. ብመውስቦ ንግዲ እትመሓደር/ፈይቶት/
19. ካሊእ (ይገለፅ)-------------------
መ.
ቑ
3ይ ክፋል: ን ናይ ኤች.አይ. ቪ/ኤድስ ህክምና ዘለዎ
ድልየት መዐቀኒ
ነቲ ሕቶ ዝተውሃበ መልሲ መብርሂ
301 ንመጀመርያ ጊዜ ኤች .አይ . ቪ ቫይረስ አብ ደምካ ምህላዉ
መዓዝ ተነጊርካ ወይ ከዓ ፈልጥካ ?
_____/____/_____ዓ.ም
302 ንመጀመርያ ጊዜ ኤች .አይ . ቪ ቫይረስ አብ ደምካ ምህላዉ
አበይ ተነጊርካ ወይ ፈልጥካ?
1. አብዚ ጥዕና ትካል
2. ካሊእ(ይገለፅ)
303 ንመጀመርያ ጊዜ ኤች .አይ . ቪ ከም ዘለካ አብ ዝሰማዕካሉ
ጊዜ ናይ ኤች .አይ . ቪ ምርመራ ዝገበርካሉ/ክሉ ምክንያት
እንታይ ነይሩ?
6. ብዓርሰ ድልየት ዝግበር ምርመራ
7. ብበዓል ሙያ ምልዕዓል ዝግበር ምርመራ
8. ካብ አዶ ናብ ዕሸል ምክልኻልፕሮግራም
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9. ብዝነበረኒ ሓደገኛ ተጓንፎ
10. ምልክታት ብምርአይ
11. ካሊእ (ይገለፅ)----------------------------
304 ኤች.አይ. ኤድስ ብከመይ ሓልፊካ/ኪ? 1. ንዝሐመመ ዘመድ ክንክን አብ ምግባር
2. ብፆታዊ ርክብ
3. በላሕቲ ነገራት ብመጥቃም
4. ካሊእ (ይገለፅ)
305 መጀመርያ ን ኤች.አይ.ኤድስ ሕክምና  ክትመፅእ ከለካ
ከምኒ ሕማም ሽኮርያ ፣ድፊኢት ደም ፣ናይ ልቢ ድኻም
ወዘተ ነይርካ ድዩ ?
1. እወ 2. አይነበረንን
306 ንመጀመርያ ጊዜ ናብ ኤች .አይ . ቪ ኤድስ ሕክምናን
ክንክን ንክትመፅእ እንታይ አለዓዕልካ/ኪ?
11. ውሉደይ፣ቤተሰበይን ዓርሰይን ንምክልኻል ክብል
12. ናይ ምክልኻል ዋህዮታተይ ንምፍልጥን አድላዪ
አብ ዝኮነሉ ሕክምና ንምጅማርን
13. ቤተ ሰበይ፣ብዓልቲ ቤተይን ስለ ዘተባበዑኒ
14. ካሊእ መድሓኒት ብምጥቀም ስለ ዘይሓሸኒ
15. ብጣዕሚ ስለ ዝሐመምኩ
16. ፅኑዕ ሕማም /ሞት ብምፍራሕ
17. ሕክምና ብምወሳድ ዘሎ ዝሓሸ ህይወት ተስፋ
ብምግባር
18. ናይ ኤች .አይ . ቪ ኤድስ ሕክምና ግድን ምካኑ
ስለ ዝፈልጥ
19. አይፈልጦን
20. ካሊእ(ይገለፅ)
ካብ 1
ንላዕሊ
መልሲ
ይከአል
እዩ፡፡
307 ቕድሚ ናብ ኤች .አይ . ቪ ኤድስ ሕክምና ምምፃእካ ካሊእ
ፈውሲ/መድሓኒት መኩርካ ነይርካ ዶ ?
2. እወ 2. አይሞኮርኩን
308 ንቁፅሪ 307 እወ እንተኮይኑ እንታይ ዓይነት መድሓኒት? 6. ባሕላዊ ሕክምና/መድሓኒት
7. ካብ መድሓኒት መከፋፈልቲ ትካላት/ፋርማሲ
8. ሀይማኖታዊ
9. ኣብ ገዛ ዝተሰርሐ መድሓኒት
10. ካልእ (ይገለፅ)---------------------
ካብ 1
ንላዕሊ
መልሲ
ይከአል
እዩ፡፡
መ.
ቑ
4ይ ክፋል: ፍልጠት ፀረ- ኤች.አይ. ቪኤድስ ህክምና
ዝምልከት
ነቲ ሕቶ ዝተውሃበ መልሲ መብርሂ
401 ቕድሚ መጀመርያ ናብ ክንክን ምምፃእካ ስለ ኤች .አይ .
ቪ ኤድስ ህክምናን ክንክንን ሰምዕካ ዶ ትፍልጥ ?
1. እወ 2. አይፈልጥን 2 ናብ
5ይ ክፋል
403 ቕድሚ ናይ ኤች.አይ.ቪ ኤድስ ህክምና ምጅማርካ ካብ ዞም
ሲዒቦም ዘለው አየናይ ትፈልጥ ነይርካ ?
ፀረ- ኤች .አይ. ቪ ኤድስ ሕክምና ብናፃ አብ ሆስፒታል
ወይ ከዓ ጥ/ጣብያ ከምዝርከብ
1. እወ 2. አይፈልጥን
ፀረ ኤች .አይ . ቪ ኤድስ ሕክምና ብምውሳድ ምስ ኤች
.አይ . ቪ ኤድስ ዘይብሉ ሰብ ተመሳሰሊ ዕድመ ምንባር
ከምዝከኣል
1. እወ 2. አይፈልጥን
ፀረ- ኤች .አይ .ቪ ኤድስ ሕክምና ንዕድመ ልክዕ ዝውሰድ
መድሓኒት ምኳኑ
1. እወ 2. አይፈልጥን
ፀረኤች .አይ. ቪ ኤድስ ሕክምና ብጣዕሚ ከይሐመምካ
ከምዝጅመር
1. እወ 2. አይፈልጥን
ኤች .አይ . ቪ ኤድስ ዘለዋ አዶ ፀረ-ኤች .አይ . ቪ ኤድስ
ሕክምና ምውሳድ ከምእትኽእል
1. እወ 2. አይፈልጥን
ፀረ ኤች .አይ. ቪ ኤድስ ሕክምና አብ ደም ዘሎ ናይ ቫይረስ
መጠን ከምዝቕንስ
2. 1. እወ 2. አይፈልጥን
መ.
ቑ
5ይ ክፋል: ን ፀረኤች.አይ. ቪኤድስ ሕክምና ምጅማር
ዕንቅፋት ዝኮኑ ነገራት
ነቲ ሕቶ ዘተውሃበ መልሲ መብርሂ
501 ፀረኤች .አይ . ቪ ኤድስ ሕክምና ንከይትጅምር ዕንቅፋት
/መሰናኽል ዝኮኑካ ነገራት ነይሮም ዶ?
1. እወ 2. አይነበረነን 2 ናብ
503
60
502
ካብ ዞም ስዒቦም ዘለዉ አየነአም ምኽንያታት ዕነቅፋት
ኮይኖምካ/ኪ
1. ፀረ ኤች .አይ . ቪኤድስ ሕክምና ብዝፈልጦም
ሰባት ሰለዝወሃብ
2. ንመጓዓዝያ ዝከውን ገንዘብ ስለ ዝሓፅረኒ
3. ኤች .አይ .ቪ ክሊኒክ አብ ዝምችው ሰዓትን
መዓልቲን ስለዘይኽፈት
4. ናይ ኤች .አይ . ቪ ሕክምና ክወስድ ከለኩ
ዝፈልጠኒ ስብ ከይርእየኒ ብምፍራሕ
5. አብ ሐዳረይ ዝፍጠር ጎንጺ/ህውከት ብምፍራሕ
6. አብ እቶተይ/ስራሐይ ዘጋጥመኒ ክስራን
ብምፍራሕ
7. ናይ ፀረ ኤች .አይ .ቪ ኤድስ መድሓኒት ጎድናዊ
ሳዕቤን ብምፍራሕ
8. ኤች.አይ.ቪ ከም ዘለኒ ንሰባት ምቅላዕ/ምግለፅ ስለ
ዘፍርሓኒ
9. ካብ ሕብረተሰብ ዝመፅእ ምጽላም/ምግላል
ብምፍራሕ
10. ገንዘብ ብበዓል ገዘይ ስለ ዝውነን
11. አገልግሎት አብ ምርካብ ዘሎ ነዊሕ ተራ
ብምፍራሕ
12. ነዊሕ ርሕቀት ወይ ከዓ ነዊሕ ስዓት ምጓዓዝ
13. ፀረ ኤች .አይ .ቪ ኤድስ መድሓኒት አበይ ከም
ዝርከብ ስለ ዘይፈልጥ
14. ካሊእ (ይጠቀስ)
ካብ
ሐደ
ንላዕ
ሊ
መል
ሲ
ምሃ
ብ
ይከአ
ል
እዩ፡፡
503 ገዛካ/ኪ ካብቲ ዝቐረበ ኤች. አይ .ቪ ሕክምና ዝወሃበሉ
ትካል ብክንደይ ይርሕቕ
----------ኪሎ ሜትር፣ብእግሪ ጉዕዞ ዝወስዶ ሰዓት ----
-------- ሰዓት
PL
መ.
ቑ
6ይ ክፋል : ባህርያዊ ኩነታት ዝምልከቱ ሕቶታት ነቲ ሕቶ ዝተውሃበ መልሲ መብርሂ
601 ቅድሚ ን ኤች. አይ.ቪ ሕክምና ምምጻእካ አብ 1 ዓመት
ውሽጢ መስተ ትሰቲ ዶ ነይርካ/ኪ?
2. እወ 2. አይሰትይን 2 ናብ
603
ሕለፍ
602 ን ቑፅሪ 501 እወ እንተኮይኑ አብ መዓልቲ ብ ማእኸላይ
ክንደይ ትሰቲ ነይርካ/ኪ?
4. 1-2 መስተ አብ መዓልቲ
5. 3-4 መስተ አብ መዓልቲ
6. 5-6 መስተ አብ መዓልቲ
603 አብ ህይወትካ/ኪ ክንደይ ፆታዊ (sexual partner) መሐዛ
ነይረናካ/ ነይሮምኪ?
4. ምንም አይነበረንን
5. ሓደ
6. ክልተ
7. ካብ ክልተ ንላዕሊ
604 አብ ህይወትካ ነፍሰን ሸይጠኝ ምስ ዝመሓደራ /ፋይቶት/
ጾታዊ ርክብ ፈፅምካ ትፈልጥ ደ ?
3. እወ
4. ኣይፈልጥን
ን201
ተባ
ጥራሕ
መ.
ቑ
7ይ ክፋል ፡ ኩነታት ማሕበራዊ ከባቢ ዝምልከቱ
ሕቶታት
ነቲ ሕቶ ዝተዉሃበ መልሲ መብርሂ
701 መጀመርያ ናይ ኤች.አይ.ቪ ኤድስ ክንክን እንትጅምር
ከለካ/ኪ ምስ መን ትነብር ነይርካ/ኪ?
4. ንብሕቶ
5. ምስ ስድራ
6. ምስ ብዓል/ቲ ገዛይ
7. ካሊእ (ይገለፅ)__________
702 መጀመርያ ን ኤች.አይ.ቪ ክንክን ክትመፅእ ከለካ አብ ገዛ
ካሊእ ምስ ኤች አይ ቪ ዝነብር ስብ ነይሩ ዶ ?
2. እወ 2.አይነበረን
703 መጀመርያ ኤች.አይ.ቪ ክንክን እንትጅምር ከለካ/ኪ ምሳካ
ዝነብር ኤች.አይ.ቪ ክንክን ዝጥቀም ሰብ ነይሩ ዶ ?
1. እወ 2. አይነበረን
704 ናብ ክንክን አብ ዝመፃእካሉ ጊዜ ንስካ እተዕብዮም ትሕቲ
10 ዓመት ቆልዑት ነይሮም ዶ ?
1. እወ 2. አይነበሩን
705 ን መጀመርያ ጊዜ ናብ ኤች .አይ . ቪኤድስ ሕክምናን 1. እወ 2. አይገለጽኩን
61
ክንክንን ክትመፅእ ከለኻ ኤች .አይ . ቪ ከም ዘለካ ንካሊእ
አካል ዓርስካ አቃሊዕካ/ገሊፅካ ነይርካ ዶ ?
706 ንቁፅሪ 705 እወ እነተኮይኑ ንመነመን ዓርስካ ገልፅካ ነይርካ
?
5. ብዓል /ቲ ገዛይ
6. ስድራ ቤት
7. ጎረቤት
8. ን ናይ ሀይማኖት ተገዳሲ/ክንክን ወሃቢ
9. ካልእ(ይጠቀስ))________________
707 ንመጀመርያ ኤች.አይ.ቪ ኤድስ ከም ዘለካ ምሰ ፈለጥካ
ዓርስካ ንምርግጋዕ ዝወሰድካዮ ስጉምቲ እንታይ ነይሩ ?
5. ንበዓል ገዛይ፣ንስድራይ፣ንሀይማኖት ተገዳሲ
ምምኻር
6. ሰብ ሙያ ባህላዊ መድሓኒት ምምኻር
7. ናይ አመጋግባን ካለእ አገባብ መነባብሮን
ለውጢ ምግባር
8. ሰብ ከይፈልጠለይ ብምስጢር ምሕላው
9. ካሊእ (ይገለፅ)
መ.
ቑ
ናይ ማሕበራዊ ድጋፍ ደረጃ መለከዒ ነቲ ሕቶ ዝተውሃበ መልሲ መብርሂ
708 ድጋፍ ዝህበካ አካል እንተደሊካ ክንደየናይ ዝአክል እዞም
ዝስዕቡ ዝገብረልካ ሐደ ሰብ /ገለ ሰብ ትረክብ ?
(ምንም አይረክብን ፣ሓደሓደ ጊዜ፣ ብዙሕ ጊዜ ፣
ዳረጋ ኩሉ ጊዜ፣ ኩሉ ጊዜ )
ካብ ዓራት ምልዓል እንተዘይክእልካ ዝረድአካ/ዘልዕለካ 2. ምኣ 2. ሓጊ 3. ብጊ 4. ዳኩጊ 5. ኩጊ
ሕክምና አብ ዝደለካሉ ጊዜ ናብ ሕክምና ዝወስደካ 1. ምኣ 2. ሓጊ 3. ብጊ 4. ዳኩጊ 5. ኩጊ
ምግቢካ ምስራሕ አብ ዝሰአንካሉ ምግቢ ዘዘጋድጅየልካ 1. ምኣ2. ሓጊ 3. ብጊ 4. ዳኩጊ 5. ኩጊ
እንድሕር ሓሚምካ ዕለታዊ ዝኮኑ ቀለለልቲ ሰራሕቲካ
ዝሕግዘካ
1. ምኣ 2. ሓጊ 3. ብጊ 4. ዳኩጊ 5. ኩጊ
ፅቡቕ ጊዜ ምስኡ ሓቢርካ ክተሕልፍ እትከእል 1. ምኣ 2. ሓጊ 3. ብጊ 4. ዳኩጊ 5. ኩጊ
ስለ ዓርሰ ሽግርካ ምኽሪ ንከማኽረካ እትተአማመኖ 1. ምኣ2. ሓጊ 3. ብጊ 4. ዳኩጊ 5. ኩጊ
ሽግርካ ብቅልጡፍ ዝርደአልካ 1. ምኣ 2. ሓጊ 3. ብጊ 4. ዳኩጊ 5. ኩጊ
ዝቐርበካን ተፈታዊነትካ ወይ ከዓ ፍቕሩ ዝገልፀልካን 1. ምኣ 2. ሓጊ 3. ብጊ 4. ዳኩጊ 5. ኩጊ
መ.
ቑ
ናይ ተስፋ ምቕባፅ ደረጃ ስምዒት መዐቀኒ ነቲ ሕቶ ዝተውሃበ መልሲ መብርሂ
709 ኤች . አይ . ቪ ከም ዘለካ ካበ ፈለጥካ
አብ ህይወትካ ድሱት ድካ ? 2. እወ 2. አይኮንኩን
ሐደ ሐደ ጊዜ ህይወተይ ባዶ እዩ ዝብል ስምዕት ይስምዓካ
ዶ ?
2. እወ 2. አይስመዓንን
ሓደ ፅቡቕ ዘይኮነ ነገር ከይበጽኒ ኢልካ/ኪ ተጨንካ ዶ
ትፈልጥ?
2. እወ 2.አይፈልጥን
መብዛሕቲኡ ጊዜ ደስታ ይስመዓካ ዶ ? 1. እወ 2. አይስመዓንን
መ.
ቑ
ዓርስካ ኣዋረድካ/ኣኽፍአ ናይ ምርአይ ስምዕት መዐቀኒ ነቲ ሕቶ ዝተውሃበ መልሲ መብርሂ
710 ካብዞም ዝሰዕቡ አየናይ ስምዒት ይስመዓካ ?
ኤች.አይ.ቪ ከም ዘለኒ ንሰባት ምንጋር ብጣዕሚ ይከብደኒ 2. እወ 2. አይከብደንን
ኤች.አይ.ቪ ቫይረስ አብ ደመይ ስለዘለኒ ንፁህ ከም ዘይኮንኩ
ይስመዓኒ
2. እወ 2. አይስመዓንን
ኤች.አይ.ቪቫይረስ አብ ደመይ ስለ ዘለኒ በደለኛ ከም ዝኮንኩ
ይስመዓኒ
2. እወ 2. አይስመዓንን
ኤች.አይ.ቪ ቫይረስ አብ ደመይ ምህላዉ ብጣዕሚ የሕፍረኒ 2. እወ 2. አየሕፍረንን
ኤች.አይ.ቪ ቫይረስ አብ ደመይ ስለ ዘለኒ ሓደ ሓደ ጊዜ ዋጋ
ዘይብለይ መሲሉ ይስመዓኒ
2. እወ 2. አይስመዓንን
ኤች.አይ.ቪቫይረስ አብ ደመይ ምህላዉ ካልአት ከይፈልጡ
ይሓብኦ እየ፡፡
2. እወ 2. አይሓብኦን
መ.
ቑ
8ይ ክፋል፡ አብ ሕብረሰብ ደረጃ ዝፍጠሩ ምኽንያታት ነቲ ሕቶ ዝተውሃበ መልሲ መብርሂ
801 አብ ከባቢኩም ብ ኤች.አይ.ቪ ዙርያ ዝንቀሳቀሱ ድጋፍ
ወሃብቲ ጉጅለታት ነይሮም ዶ ?
2. እወ 2. አይነበሩን
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802 ን ቁጽሪ 701 መልሶም አወ አንተኮይኑ እንታይ ዓይነት
ድጋፍ ውሃብቲ ጉጅለ እዮም?
4. ናይ ሕብረተሰብ ድጋፍ ውሃብቲ ጉጅለ
5. ሃይማኖታዊ ድጋፍ ውሃብቲ ጉጅለ
6. ምስ ኤች ቪ ዝነብሩ ድጋፍ ውሃበቲ ጉጅለ
3. ካሊእ (ይገለፅ)
መ.
ቑ
ካብ ሕብረተሰብ ንዝውሃብ ምፅላም ምስክርነት ነቲ ሕቶ ዝተውሃበ መልሲ መብርሂ
803 ኤች.አይ.ቪ ስለ ዘለዎ/ዋ ካብዞም ሰዒቦም ዘለዉ
ኣድልዎታት ዝበፅሖ ሰብ አብ ከባቢካ አጋጥምካ/ኪ ዶ
ይፈልጥ ?
ካብ ስራሑ ዝተባረረ፣ደንበኛኡ ዝስአነ/ ወይ ዝከሰረ 1. እወ 2. አይፈልጥን
ዓርኩ/ካ ዝኻሕደቶ/ዳ ወይ ካዓ ዝገደፋ/ፈቶ 1. እወ 2. አይፈልጥን
ሰብ ዝሓጨጮ 1. እወ 2. አይፈልጥን
አካላዊ በደል ዝበፅሖ 1. እወ 2. አይፈልጥን
አብ ሕብረተሰቡ ወይ ከዓ ስድራኡ ዝነበሮ ክብሪ ዝሰአነ 1. እወ 2. አይፈልጥን
መ.
ቑ
9ይ ክፋል፡ ናይ ቤተሰብ ሃብቲ መጠን መለከዒ ሕቶታት ነቲ ሕቶ ዝተውሃበ መልሲ መብርሂ
901 C. ን ከተማ ነበርቲ 206
ከተማ
ናይ ውልቀ መንበሪ ገዛ 2. አለኒ 2. የብለይን
ኤሌክተርክ 2. አለኒ 2. የብለይን
ሬድዮ 2. አለኒ 2. የብለይን
ቴሌ ቪዥን 2. አለኒ 2. የብለይን
ሞባይል ስልኪ 2. አለኒ 2. የብለይን
ናይ ገዛ ስልኪ 2. አለኒ 2. የብለይን
ፍሪጅ 1. አለኒ 2. የብለይን
ጠረጴዛ 1. አለኒ 2. የብለይን
ወንበር 1. አለኒ 2. የብለይን
ፍራሽ(ስፖንጅ፣ጡጥ ፣ጨርቃ ጨርቂ) ዘለዎ ዓራት 1. አለኒ 2. የብለይን
ናይ ኤሌክተሪክ /ዕንጨት ቆጣቢ/ ምድጃ 1. አለኒ 2. የብለይን
ናይ ቤተ ሰብ ወርሓዊ አታዊ ብማእኸላይ _________________________ ብር
902 D. ን ገጠር ነበርቲ ነቲ ሕቶ ዘተውሃበ መልሲ ን 206
ገጠር
ናይ ውልቀ ገዛ 1. አለኒ 2. የብለይን
ሬድዮ 1. አለኒ 2. የብለይን
ሞባይል ስልኪ 1. አለኒ 2. የብለይን
ፍራሽ (ስፖንጅ፣ጡጥ ፣ጨርቃ ጨርቂ) ዘለዎ ዓራት 1. አለኒ 2. የብለይን
ኩራዝ / ፋኑስ 1. አለኒ 2. የብለይን
ዓመታዊ ናይ ሕርሻ አታዊ ብኩንታል _____________________ኩንታል
ብቤተሰብ ደረጃ ክንደይ ዝሕረስ መሬት ይውነን ________________ብ ጽማድ
ብቤተሰብ ደረጃ ክንደይ እንስሳ ዘቤት አለኩም?
አላሕም፣ኣቡዑር፣ ______________ብ ቑፅሪ
ፈረስ, አድጊ, በቕሊ ______________ ብ ቑፅሪ
ኣጣሊ ______________ ብ ቑፅሪ
በጊዕ ______________ ብ ቑፅሪ
ደርሁ ______________ ብ ቑፅሪ
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FGD Guide: Tigrigna Version
1. ሰባት ናብ ኤች . አይ . ቪ ሕክምና ቀልጢፎም  ዘይመፅእሉ /ብጣዕሚ ምስ ሓመሙ  ዝመፅእሉ
ምክንያት አንታይ እዩ ?
2. ተጠቀምቲ ካብ ኤች.አይ.ቪ  ኤድስ ሕክምና ወፃኢ ካሊእ መድሓኒት  ዝጥቀሞ  ነግር እንታይ አሎ ?
3. አብ ከይዲ ምርካብ ናይ ኤች .አይ.ቪ ኤድስ ሕክምና መብዛሕቲኦም ሰባት ዝድንጉዩሉ ደረጃ አብ ምንታይ
እዩ ?
ሀ. ምርመራ  አብ ምግባር / ዓርሰካ አብ ምፍላጥ ድዩ ? ወይስ
ለ. ዓርሰካ ምስ ፈለጥካ ሕክምና አብ ምጅማር እዩ ?
4. አብ ምንታይ ዕድመ ደረጃ ዘለው እዮም ዘንግኦም ዝመፁ ;
ደቂ ተባዕትዮ ድዮም ወይስ ደቂ አንስትዮ እዮም ብብዝሓት  ዘንግዖም  ዝመፁ
ሐዳር ዘለዎም ድዮም ወይስ  ዘይብሎም  እዮም ?
5. አብ ሕብረተሰብ ደረጃ ሰባት  ናብ ኤች አይ ቪ ሕክምና  ንከይመፅእ ዝገብሩዎ ነገራት  አንታይ
እንታይ እዮም ? ንክጥቀም ዘየበራትዑን ንክጥቀም ዘበራትዑን
6. ናይ ኤች አይ ቪ ሕክምና አብ ምጥቃም ሰባት ዝሐስብዎም ዕንቅፋታት አንታይ  እንታይ እዮም ?
7. ሰባት ዘንጊዖም ንከይመፁ እንታይ ምግባር ይከአል ?
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